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The amino acids are a class of biomolecules which is obligatory to terrestrial life, 
alongside nucleic acids, fatty acids and monosaccharides. The amino acids, with the exception of 
glycine, are chiral molecules which exist as either L- or D-amino acids. Although identical with 
regard to physical and chemical properties, the enantiomeric forms rotate plane-polarized light in 
opposite directions. The difference in stereoconfiguration of D- and L-amino acids can impact 
their biochemical properties, as a consequence of differential interactions with other chiral 
biomolecules, often leading to substantial differences in physiological significance. 
Originally, the L-amino acids and D-sugars were considered to be isomeric forms 
naturally present in living systems, often referred to as the homochirality of life. Over time, in 
the wake of measurements of D-amino acids in bacteria and animals dating back to the mid-
1900s, the idea of the homochirality of life was adapted to state that chiral biomolecules exist 
almost exclusively in one enantiomeric form. After several decades of research, it is now evident 
that the D-amino acids are found in every domain of life (Archaea, Bacteria and Eukarya). 
Beyond their ubiquitous presence, a few D-amino acids have been demonstrated to act as cell-to-
cell transmitters and functional roles in the central nervous and endocrine systems have been 
uncovered.   
 In spite of great progress made in our understanding of the D-amino acids in nature over 
the past several decades, many questions remain regarding the D-amino acids, the complement of 
proteins involved in their production, transduction, transport and degradation as well as 
functional importance. These gaps in knowledge emanate from the analytical challenges in D-
amino acids measurement. Beyond the conventional challenges of bioanalytical chemistry, 
analyzing the D-amino acids requires approaches which can discriminate on the basis of chirality 
as well as overcome the challenges presented by heterogeneous distribution and low abundance. 
Herein described is a body of work relating to methodological advances to facilitate the analysis 
of the D-amino acids as well as the characterization of D-amino acids in cells and tissues from the 
central nervous and endocrine systems of animals, from mollusks to man.  
 Regarding the goal of developing approaches for D-amino acid analysis, chiral 
separations involving capillary electrophoresis and liquid chromatography have been developed 
and characterized. Capillary electrophoresis paired with laser-induced fluorescence was 
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leveraged for single cell analysis, and an online sample preconcentration method was developed 
for further enhancement of sensitivity. Liquid chromatography couple with mass spectrometry 
was used for the measurement of the D-amino acids as well as the execution of pulse-chase 
experiments. Additionally, protocols for the extraction, purification and derivatization of the D-
amino acids have been explored. Together, these methodological advances were paired with 
experiment design and targeted sampling in order to characterize the D-amino acids in the central 
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Introduction and Overview 
 
 
The identification and characterization of signaling molecules is critical to furthering our 
understanding of chemical communication in nature — for example, ascribing a molecular basis 
to an emergent behavior is compromised when signaling pathways remain concealed. To the 
surprise of many, well over a decade after the completion of the human genome project, novel 
transmitters and modulators are still being discovered. Chemical complexity, cellular 
heterogeneity, low analyte abundance, matrix effects and challenging sampling conditions are 
some of the many factors which continue to plague efforts to uncover and characterize signaling 
molecules in biology. Encouraged by the clear need for effective measurement tools, analytical 
chemists continue to develop approaches with improved figures of merit to carryout increasingly 
demanding assays. Specifically, technological and methodological advances are enabling 
previously out-of-reach measurements to be made and by extension allowing for the archive of 
information regarding the molecular basis of biology to continue to grow. 
 This thesis and the work presented within are focused on two interlocking themes. The 
first theme of this thesis work is analytical development to facilitate the measurement of the D-
amino acids in biological samples. The second theme is the characterization of the D-amino acids 
in the central nervous and endocrine systems across the Metazoa. The D-amino acids are a class 
of molecules which are insufficiently characterized, where many pathways remain buried and the 
registry of D-amino acid-affiliated proteins, such as enzymes for production and receptors, 
remains incomplete. Although the past half century of D-amino acid investigations has greatly 
advanced our understanding the class of molecules as they pertain to physiological and 
pathological contexts across many organisms (from mollusks to man), the unique challenges of 
chiral measurement combined with the ever-present obstacles of bioanalytical research continue 
to limit our discovery and characterization of the D-amino acids. The work presented here 
focuses on the persisting challenge to expanding our understanding of D-amino acids in nature; 
specifically, through methodological advances and their subsequent application for investigating 
the D-amino acids in cells, tissues and releasate. 
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 The ubiquitous presence of the D-amino acids and related proteins are described in 
Chapter 2. This chapter identifies the conserved presence of the D-AAs across the tree of life 
and also places our understanding of this class of biomolecules alongside other ancient signaling 
molecules. Chapter 3 discusses the diverse tools available to researchers to measure the D-
amino acids, where the strengths and weaknesses of popular chiral approaches are covered and 
forecasts for technical developments are made. Additionally, noteworthy findings from 
applications of the discussed measurement approaches over the past several decades are shared. 
An overview of D-aspartate in non-mammalian animals is shared in Chapter 4. The overview of 
D-aspartate includes background on involvement of the molecule in signaling in the nervous, 
exocrine and endocrine systems. Additionally, a major focus of this chapter is the suite of 
analytical approaches routinely employed for D-amino acid characterization. Finally, this chapter 
also synthesizes a summary of the various uncovered functional roles for D-aspartate in 
nonmammalian animals. Chapter 5 focuses on the development of a large-volume sample 
stacking chiral capillary electrophoresis method. Additionally, the results from characterizing the 
performance of the developed method with regard to limits of detection, repeatability and salt 
tolerance are shared. The chapter goes on to describe single cell measurements of the enigmatic 
D-glutamate and well-characterized D-aspartate with the developed method. Chapter 6 describes 
a variety of projects regarding novel methods and applications for the measurement of the D-
amino acids in a variety of biological systems. Although these projects have not reached 
publishable quality, they have yielded interesting preliminary results and are great prospects for 
future D-amino acid investigations. These projects include the development of multiple online 
preconcentration approaches for capillary electrophoresis, the design, production and 
characterization of a simple device for small volume-sample handling as well as D-amino acid 
measurements in the pancreas and pancreatic islets of rodents and man. Chapter 7 provides a 
summary of this thesis and also discusses opportunities for research to expand upon the work 
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Introduction 
A zoo, which represents a small snapshot of the different lifeforms found across our 
planet, showcases not only the easily observed phenotypic differences between animals, but also 
an enormous breadth of habitats, diets and behaviors. This vast diversity of life can also be 
visualized by scanning through the limbs and branches of a phylogenetic tree. With that said, 
phylogenetic trees also invite inspection at a more fundamental level. And it is with that deeper 
evaluation that the underlying constants in life become apparent. Specifically, “molecular 
tropes,” the universal chemical underpinnings to all life (as we know it), are readily identified.  
From the ancient comb jellies, which have existed for over 500 million years, to the 
recently diverged Homo sapiens, there is a universal reliance on the central dogma of biology. 
By extension we tend to see the same chemical species (e.g. amino acids, nucleic acids) utilized 
for metabolism, construction of macromolecules and cell-to-cell signaling. Correspondingly, the 
proteins required to produce, transduce and degrade these molecules are also commonly 
observed. As a prime example, L-glutamate (L-Glu) is involved in numerous metabolic pathways 
and used for synthesis of proteins across the three domains of life (Archaea, Bacteria and 
Eukarya). Furthermore, L-Glu has been shown to act as a transmitter in a multitude of contexts 




The Fundamentals of Chirality and the Homochirality of Life 
Chirality is defined as the property of asymmetry, where a given object or system is 
chiral if it is unique from its mirror image in that it cannot be superimposed onto it. Perhaps the 
most common example of the property of chiral are human hands, where the mirror image of a 
right hand looks like a left hand and irrespective of rotation and translation, a right hand cannot 
be placed atop a left hand such that they coincide. This geometric property is important in many 
fields of science (e.g. Physics, Chemistry and Biology).  
In the field of Chemistry, many molecules and ions are chiral. The sub-field of 
stereochemistry focuses on the study of isomeric species which differ in the three-dimensional 
orientation of atoms in space, where non-superimposable, mirror image stereoisomers are 
defined as enantiomers. The amino acids and monosaccharides are classes of biomolecules 
which are often used as examples of compounds which can exist as enantiomeric pairs. 
Enantiomers are often also referred to as optical isomers because enantiomers exhibit identical 
physical properties except for the direction they rotate plane-polarized light and their interactions 
with chiral environments and entities. 
Considering the potential for existing in either enantiomeric form, nomenclature 
conventions were developed. For describing the empirically determined direction an enantiomer 
rotates plane-polarized light the prefixes (+) and (-) are used for clockwise and counter-
clockwise rotations respectively. Alternatively, the prefixes d and l can be used for designation 
of dextrorotary (clockwise) or levorotary (counter-clockwise) respectively. Regarding 
identifying prefixes which are based on configuration stereochemistry, the labels D and L are also 
used, where the label used is based on comparing the molecules spatial arrangement of atoms to 
that of glyceraldehyde, the simplest chiral monosaccharide. D- and L-glyceraldehyde were 
arbitrarily designated labels for (+)- and (-)-glyceraldehyde respectively. Finally, the labels R 
(rectus) and S (sinister) can be used for the unambiguous assigning of absolute configuration in 
accordance with the rules developed by Cahn, Ingold and Prelog. Because the prefixes designate 
different attributes, such as absolute configuration or optical activity, it is important to note that 
the prefixes are not readily exchangeable. As an example, although D-aspartate corresponds to R-
aspartate, D-cysteine corresponds to S-cysteine.  
The first chiral separation in a laboratory was achieved by Louis Pasteur in 1848, where 
he manually separated enantiomerically pure crystals of tartrate with tweezers. Pasteur went on 
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to discover chirality when he identified that the crystals which formed were mirror-images of one 
another. Since its advent, our knowledge of chirality as it pertains to Chemistry grew rapidly. 
Based on the routine observation of L-amino acids and D-sugars in living organisms, the concept 
of the “homochirality of life” was eventually born. This concept points out the exclusive use of 
left-handed amino acids and right-handed sugars in life. At first, the presence of the other 
enantiomeric forms was believed to be an artifact of analysis or accidentally present. It is 
straightforward to understand why this was believed, considering the rarity and low abundances 
of the alternate forms. Additionally, the benefits — or arguably requirement — of homochirality 
for the development of life are clear. The homochirality of life, how it was achieved on Earth, 
whether or not it is a chemical imperative for life all remain active areas of research, thought and 
speculation.  
It was not until the measurements of the D-amino acids in Bacteria and then Metazoa in 
the mid-1900s that this view was challenged. As additional evidence of the endogenous 
presence, and even function, of D-amino acids in nature surfaced the definition of the 
“homochirality of life” was adjusted to state that nature almost exclusively uses the left-handed 
amino acids and right-handed sugars. The discovery and characterization of D-amino acids in 
living organisms remains an important and growing area of research, where establishing D-serine 
and D-aspartate as bona fide transmitters are the two exemplar achievements from the past 
several decades.  
 
Molecular Signaling Overview 
Broadly speaking, an organism is a network of parts which function interdependently. In 
the case of an animal, such as a human, the network of parts would be the various organs; with 
regard to single-celled life, the various organelles can be considered as the interdependent parts. 
Although these two examples differ considerably in scale, where a human body is comprised of 
over 1013 cells, it is clear that an effective means of communication is required proper 
organismal function. For single-celled life and multicellular organisms, intercellular 
communication is routinely achieved via extracellular chemical signaling. In order to be 
considered an extracellular signaling molecule, the following criteria must be met:2 
1. Synthesis of the signaling molecule by the signaling cell. 
2. Controlled release of the signaling molecule by the signaling cell. 
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3. Transport of the signaling molecule to the target cell. 
4. Detection of the signaling molecule by the target cell. 
5. An induced change in the target cell (e.g. change in cellular function or metabolism). 
6. Signal termination by removal or degradation of the signaling molecule. 
The distance over which the signal acts defines extracellular transmitters as autocrine, 
paracrine or endocrine signaling molecules. In the case of autocrine transmitters, the signaling 
cell is also the target cell. An example of autocrine signaling is the autocrine positive feedback 
loop of γ-aminobutyric acid in human beta cells.3 Regarding paracrine signaling, the target cell is 
in close proximity to the signaling cell. Although the cell body for a neuron can be far away from 
the synaptic release site, the proximity of the release site to the target result in the classification 
of neuronal signaling as paracrine signaling. Finally, endocrine signaling describes signaling 
paradigms where the target cell is far away from the signaling cell. Returning to pancreatic islets, 
a canonical example of endocrine signaling is that of insulin response, where the insulin 
hormone is released in response to an increase in circulating glucose levels.4 
 
The D-Amino Acids as Transmitters Throughout Nature 
The presence of the D-AAs across the Metazoa5 is another commonality between this 
class of molecules and other ancient transmitters, Figure 2.1. The Pacific sea gooseberry,6 
California sea hare,7-9 and the common octopus10  are a few examples of marine invertebrates 
known to contain the D-AAs. This class of molecules has also been found in non-mammalian 
vertebrates (e.g. frog,11-14 lizard,15-17 fish,18,19 and chicken19,20) as well as mammalian vertebrates 
such as rat21-29 and human.22,30,31 This concise list reflects the ever-present nature of the D-AAs, 
where these molecules are found in animals which vary widely in characteristics such as habitat, 
diet, and evolutionary age.  
As with other ancient signaling molecules, the D-AAs and the proteins required for their 
production, signal transduction and degradation, all predate animal life. D-Ala, D-Asp, D-Glu, D-
Pro and D-Ser have been measured within proteins and as free AAs in archaea.32,33 Additionally, 
investigations in hyperthermophilic archaea have uncovered D-aspartate racemases.32 Regarding 
Bacteria, D-AAs have been shown to be present and involved in a variety of biological processes. 
Additionally, it has been demonstrated that Bacteria express a number of racemases and 
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transaminases for D-AA production.34 Thus, Bacteria fulfill the criteria required for the 
appropriation of D-AAs for signaling.  
Comparison of the assemblages of proteins capable of synthesizing free D-AAs between 
Bacteria, Archaea and Metazoa makes apparent some distinct differences, Table 2.1. With 
regard to animals, enzymes capable of producing free D-Asp,21,27,35-37 D-Ser,36-38 D-Ala39-42 and D-
Glu27 have been shown. There are no known enzymes for the synthesis of the other D-AAs in 
animals. The existence of a proline racemase in animals has been hypothesized, but not isolated 
or characterized.43 With that said, synthesis of D-Pro in a eukaryote has been demonstrated in the 
unicellular parasite Trypanosoma cruzi.44 The D-AAs and their related proteins continue to be 
regularly excavated in animals – such as the discoveries of a second aspartate/serine racemase in 
Aplysia,37 a glutamate cyclase in mouse,45 and of serine racemase expression in human islets.46 
As the puzzle of pathways and chemical players continues to be pieced together, we are afforded 
opportunities to understand the biological underpinnings from which these differences emanate. 
It has been shown that some D-AAs have been recruited for cell-to-cell signaling in 
animals, where D-serine (D-Ser)23,24,38,46-51 and D-aspartate (D-Asp)7-9,12,17,21,26,27,31,35,52-54 are the 
two most extensively studied. The characterization of D-Ser and D-Asp as transmitters has 
spanned many decades, where the investigations have focused on uncovering physiological 
relevance through the measurement of abundance, localization, production, release and 
degradation. With regard to D-Ala,28,55-59 D-Pro43,55,56,59 and D-Glu,6,8,26,45,60 these D-AAs have 
been studied in a number of vertebrate and invertebrate model organisms. As a consequence of 
being less comprehensively investigated, there are many outstanding questions regarding the 
characteristics and physiology of D-Ala, D-Pro and D-Glu. The remaining D-enantiomers of the 
common amino acids are much less frequently studied in animals; fittingly, less is known 
regarding connections with metabolic and signaling pathways for the remaining D-AAs.61,62  
 
D-Serine 
 Of the D-amino acids identified to be present in animals, D-serine has been the most 
extensively investigated. The first measurement of D-Ser in the brain was achieved by 
Hashimoto, where he determined D-Ser was present at 270 ± 10 nmol/g wet weight in perfused 
rat brain, comprised of telencephalon, diencephalon and midbrain, by gas chromatography.24 
These measurements by Hashimoto came decades later than initial measurements of free D-Ser in 
8 
 
animal tissues, specifically earthworms63 in 1960 and silkworms in 1962.64 The determined D-
Ser levels corresponded to 23% of the total free serine in the brain tissues.  
In the decades following this discovery, the abundance, localization, synthesis, uptake, 
degradation and function of D-Ser has been the focus of many investigations. D-Ser is produced 
by serine racemase65 and its degradation is catalyzed by D-AAO as well as serine racemase. It 
was shown that D-Ser binds the glycine-binding pocket of the N-methyl-D-aspartate receptor 
(NMDAR) as a co-agonist.66 Additionally, a neuronal signaling mechanism has been suggested 
by Wolosker and coworkers.67 The characterization of the molecule, the synthesis, signaling and 
degradation pathways as well as the enzymes integrally involved in these pathways led to the 
establishment of D-Ser as a transmitter. 
As a co-agonist of NMDARs, D-Ser acts as an important transmitter in the adult brain. 
Correlations between memory and cognition and D-Ser levels have been determined. With 
decreased D-Ser production via serine racemase knockout or aging, reduced performance on 
cognition tasks was observed with mice.68-70 Analogously, increased D-Ser through either 
inhibition of D-AAO or through D-Ser supplementation in feed showed improved cognitive 
performance in various animal studies.71,72 Based on the connections between D-Ser, NMDARs, 
and cognition as well as the strong ties between NMDAR hypofunction and schizophrenia, it is 
unsurprising that D-Ser73 has been implicated in the disease. Strikingly, alterations in the levels 
of D-Ser, serine racemase and D-AAO have been found in schizophrenia.74 Additionally, it has 




Following D-serine, the second most extensively studied D-amino acid in animals is D-
aspartate. In 1977, D’Aniello & Giuditta determined the presence of D-Asp in the brain of 
Octopus vulgaris76 as well as additional mollusks in 1978 — Loligo vulgaris, Sepia officinalis 
and Octopus vulgaris.77 These initial measurements of D-Asp in animal tissues preceded the first 
measurement of free D-serine in animals by nearly two decades. Dunlop and coworkers reported 
free D-aspartate in rodent and human tissues and blood in 1986. Beyond determination of higher 
amounts of D-Asp in particular regions of the brain (e.g. pituitary and cerebral hemispheres), 
Dunlop and coworkers identified that D-Asp was present in higher concentration in younger 
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animals.22 Similar to D-serine, the decades of research following the initial measurements were 
focused on the uncovering of related proteins and characterizing the synthesis, localization, 
uptake, degradation and functions of D-Asp.  
Multiple enzymes which catalyze the production of D-Asp have been uncovered. 
Enzymes capable of producing D-Asp were first identified in Bacteria,78 but then were also 
identified in Archaea32 and Metazoans.79-82 A follow-up study with the transaminase determined 
in mice, GOT1L1,82 have yielded results which suggest it is not involved in D-Asp production in 
rats and humans,21 obfuscating our understanding of D-Asp chemical pathways in mammals. 
Regarding receptors, the ability of D-Asp to bind at the L-glutamate site of various glutamate 
ionotropic receptors83,84 as well as block α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) receptors,84 has been demonstrated. Additionally, the ability to act upon metabotropic 
receptors and be transported by EAATs has been shown.85-87 Moreover, the existence of 
additional uncharacterized receptors has been hypothesized based on nonspecific cation currents 
associated with D-Asp independent of L-Glu.88 With regard to the catalysis of the degradation D-
Asp, D-AspO was known to deaminate D-Asp prior the first measurements of D-Asp in animals. 
It is the case that the enzyme was used to make initial measurements via bioassay.  
In addition to the characterization of the metabolism, production, transport and 
degradation, the function of D-Asp has been the focus of many other investigations. Functional 
relevance to reproduction, development, and vision has been suggested in a variety of 
mammalian and nonmammalian species. With regard to involvement in organism development, 
it has been demonstrated that the increased expression of D-AspO with development corresponds 
with the pronounced reduction in D-Asp levels in embryonic human prefrontal cortex.89 This 
finding builds upon the initial determination of the general reduction in D-Asp levels with 
increasing age in rodents and chickens.20,22 The involvement of D-Asp in reproduction signaling 
pathways has been demonstrated in several nonmammalian species, including Pelophylax 
esculentus13,14,90-95 and Podaris sicula sicula.15,96 The involvement of D-Asp is conserved with 
mammalian species as well, for example, the mechanism of D-Asp in the production and 
secretion of testosterone has been shown with rodents and man.97 Vision is another physiological 
function for which D-Asp is thought play a role in. The suggested involvement of D-Asp in vision 
is based on its presence in the retina of many animals and has also been found in the optic lobe of 
the common cuttlefish.98 Beyond presence in the optic lob of the cuttlefish, it was shown that 
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sustained light deprivation led to a decrease in the expression of aspartate racemase as well as of 
D-Asp itself. Taken together, D-Asp has been established to act as a signaling molecule in a 
variety of physiological contexts across the Metazoa. 
 
D-Alanine 
 Although far less characterized than D-aspartate and D-serine in animals, D-alanine was 
the first D-amino acid to be conclusively measured in animal tissues, where it was measured in 
the blood of Oncopeltus fasciatus.99 The first report of D-Ala in mammals was when the 
molecule was determined to be present in the blood of mice and guinea pigs in 1965.100 Around 
this same time D-Ala was reported in mollusks and crustaceans by D’Aniello & Giuditta.76,77 
Returning to mammals, Hamase and coworkers reported the presence of D-Ala in rat and mouse 
pancreas.101 Additionally, immunohistochemical visualization showed co-localization of D-Ala 
with insulin in pancreatic islet beta cells.58 Follow-up work with manually isolated islets directly 
measured D-Ala and demonstrated its release upon stimulation with glucose.28 
 Because D-Ala has a methyl group as its side chain, the nonpolar aliphatic amino acids 
can be degraded by D-AAO. The fact that D-Ala is a substrate for D-AAO was leveraged in its 
first determination via bioassay.100 Regarding biosynthesis of D-Ala, alanine racemase activity 
has been found in fungus,102 yeast103 and marine invertebrates.40,104-106 Alanine racemase is a 
pyridoxal 5’-phosphate (PLP)-dependent enzyme which catalyzes the conversion between D- and 
L-alanine. With regard to mammals, no alanine racemases have been identified. The presence of 
alanine racemases in marine invertebrates and the accumulation of high levels of D-Ala have led 
to the suggestion of D-Ala usage as an osmolyte in these systems. The presence of high levels D-
Ala would not interfere with many other cellular processes as the D-form is not recognized in as 
many pathways as L-Ala. With regard to D-Ala production in mammals, measurements of the D-
amino acids in germ-free and specific pathogen-free mice suggest that D-Ala is microbial-
derived. This was concluded because the removal of the gut microbiota drastically reduced 
plasma D-Ala levels.107 With regard to function in mammals, although some work has been done 
regarding the characterization of D-Ala in the brain and pancreas, functional roles have yet to be 
clarified. With regard to pancreatic islets, D-Ala is a promising candidate for determination as an 
autocrine or paracrine transmitter considering the local expression of NMDARs108 for which D-




 D-glutamate is another D-amino acid which is not as well characterized or understood 
relative to D-Ser and D-Asp. D-Glu has been shown to be present in both invertebrate and 
vertebrate species, although it is less readily measured than D-Ser and D-Asp. Beyond presence 
in animals,8,60,109,110 D-Glu loads synaptic vesicles, binds the L-glutamate site of NMDARs and is 
excitotoxic.111 Moreover, the induction of muscle contraction in silkworms from application of 
D-Glu has been demonstrated,112 as has increases in intracellular levels of Ca2+ in Pleurobrachia 
bachei and Bolinopsis infundibulum muscle cell upon exposure to D-Glu.1 With regard to the 
enzymatic production of D-Glu, several known aspartate racemases and transaminases have been 
shown to exhibit glutamate racemase activity. Additionally, the presence of D-AspO, an enzyme 
which catalyzes the deamination of D-Glu, D-Asp and NMDA, and of D-glutamate cyclase, an 
enzyme which catalyzes the interconversion of D-Glu and 5-oxo-D-proline, has been identified 
across the Metazoa.94,109,113-116 In spite of the characterization work that has been done so far, D-
Glu has yet to be characterized as a transmitter. The typical low abundance and heterogeneous 
distribution of D-Glu remain major challenges to its effective characterization. 
 
D-Proline 
 D-proline, similar to D-glutamate, is another D-amino acid which is known to be present 
in animal tissues and fluids which remains poorly characterized. D-Pro is the fifth D-amino acid 
for which a eukaryotic racemase has been identified. Unlike the previously described racemases, 
the proline racemase identified in the parasite Trypanosoma cruzi is not PLP-dependent.44 It has 
been suggested that a proline racemase may exist in mice, as radioactively-labeled D-proline was 
determined to be incorporated into proteins following injection in the cerebral cortex, 
presumably following a conversion to L-proline by a proline racemase.43 Like alanine, proline is 
a nonpolar, aliphatic amino acid and therefore is a substrate for D-AAO. When acted upon by D-
AAO, D-proline is first converted to 1-pyrroline-2-carboxylic acid which then spontaneously 
breaks down into 5-amino-2-oxopentanoic acid. Although D-Pro has been measured in 







 In the decades following the initial measurement of the D-amino acids in living 
organisms, a great deal of progress has been made in the discovery and characterization of D-
amino acids and related proteins. Our understanding of the conservation and utilization of D-AAs 
across the Metazoa continues to expand alongside the growing archive of D-AAs and related 
proteins. Two D-amino acids, D-serine and D-aspartate, have been established as transmitters and 
our understanding the functional significance of D-amino acids in nervous and endocrine systems 
has expanded considerably. With the uncovering of a metabolic and signaling pathways, the 
importance of the D-amino acids as a class of signaling molecules has been highlighted many 
times over. In spite of the vast progress which has been made in the last several decades, many 
questions remain regarding presence, pathways and function of D-amino acids across the tree of 
life and with regard to particular disease-states. Accordingly, the investigation of the D-amino 





















Figure and Table 
 
Figure 2.1: A representative phylogenetic tree of Archaea (red), Bacteria (green) and Metazoa 
















D-AAs Archaea Bacteria Metazoa 
Alanine   + + 
Arginine   +  
Asparagine      
Aspartic Acid + + + 
Cysteine      
Glutamic Acid   + + 
Glutamine   +  
Histidine      
Isoleucine      
Leucine   +  
Lysine   +  
Methionine   +  
Phenylalanine      
Proline   +  
Serine   + + 
Threonine   +  
Tryptophan      
Tyrosine      
Valine   +  
Ornithine   +  
 
 
Table 2.1: A list denoting if racemases and/or transaminases for D-AA production have been 
identified in Bacteria, Archaea and Metazoa. (+) denotes that at least one enzyme capable of 
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Introduction 
Before discussing the contents of the analytical toolbox for D-AA measurement, it is 
prudent to first discuss why these tools are needed. The discovery and characterization of 
transmitters requires demonstrating a variety of attributes, notably localization, synthesis, 
release, uptake, degradation and physiological effect. Measuring these attributes requires careful 
experimental design, appropriate analytical techniques and proper execution. Consequently, 
investigations focused on discovering and characterizing transmitters require a diverse set of 
tools which perform well under a variety of experimental constraints (e.g. sample volume, 
throughput, matrix effects). 
Measuring D-AAs can be challenging, particularly for those found at low concentrations 
or which are heterogeneously distributed. These challenges are exacerbated by obstacles 
typically encountered in bioanalytical work, such as sampling challenges, chemical complexity, 
biofouling, and matrix effects. Beyond these challenges, measurements of D-AAs must also be 
able to differentiate signal from the L-enantiomers. Here we will describe the many techniques 
which have played critical roles in advancing our understanding of the D-AAs from the advent of 




Techniques for D-Amino Acid Analysis 
Liquid Chromatography (LC)  
Liquid chromatography is widely considered a workhorse technique for chemical 
separations. Fittingly, LC is a routinely employed technique for D-AA measurement, stemming 
from its robust performance, accessibility to researchers, adaptability and the availability of the 
numerous protocols which have been developed over the years. We will open our discussion of 
analytical techniques for D-AA measurement with a focus on LC paired with a variety of 
detection schemes. The revelation of the link between D-Asp levels and brain development1,2  as 
well as the initial examination regarding the prevalence and physiology of microbial-derived D-
AAs in the intestinal tract3 are among the many noteworthy achievements of LC analysis of D-
AAs.  
Liquid chromatography is a liquid phase separation technique which involves the 
pressure-driven flow of a liquid solvent through a column which contains an adsorbent material. 
The compounds in the sample plug injected onto this column are separated from one another if 
the interactions of each compound with the stationary phase and mobile phase are sufficiently 
different. Liquid chromatography refers to high-pressure liquid chromatography (also known as 
high-performance liquid chromatography) or ultrahigh-performance liquid chromatography. 
Similar to traditional liquid chromatography, which relies on gravity to drive the mobile phase, 
the techniques rely on differences in mass transfer processes to achieve separation. There are 
many variants of LC available to researchers, such as normal-phase, reverse-phase, size 
exclusion and ion exchange chromatography.   
To measure a D-amino acid without interference from the L-form, LC can be used to 
separate the enantiomers based on differential interactions with a stationary phase of the column. 
This is typically achieved in one of two ways: 1) Reacting the analytes with enantiomerically 
pure substrate, thus generating diastereomers with sufficiently different chemical properties to 
enable separation via an achiral column; 2) Employing a chiral column, where differential 
chemical interactions with each enantiomer can be used to separate D- and L-AAs from one 
another. Owing to the nearly identical chemical and physical properties of enantiomeric forms, 
identifying the experimental conditions to achieve chiral separation can be challenging. 
Over the last few decades, as LC continued to be used extensively for measurement of D-
AAs in a variety of biological samples, multi-dimensional LC as well as hyphenation of LC with 
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mass spectrometry has grown in popularity. The growing emphasis on these variants of LC was 
born out of a need for greater confidence in analyte identification and quantification. A 
substantial amount of D-AA measurement via LC employs laser-induced fluorescence detection. 
Because most amino acids are not natively fluorescent, reactive dyes such as o-phthaldehyde 
(OPA) and naphthalene-2,3-dicarboxaldehyde (NDA) have been used to enable measurement. 
Considering the chemical complexity of the biological samples studied in D-AA investigations, it 
is difficult to place confidence in the measurements except in cases where ancillary approaches 
are used. Examples of ancillary approaches include analysis of the same sample with multiple 
techniques or selective degradation of D-AA peaks through treatment with the appropriate 
degradative enzyme. Over the past decade, there have also been a number of demonstrations of 
the utility of multiple stages of LC separation as well as coupling with mass spectrometry for 
improved resolution and coverage of D-AAs.3-9 This shift in tactics for LC-based measurement of 
D-AAs will yield reliable data on D-AAs, even at low abundance, in samples large enough to be 
used with LC. 
 
Gas Chromatography (GC)  
Gas chromatography is another separation technique which has been employed for D-AA 
measurements. The attractiveness of GC extends from ease of use, moderately short run times, 
and good detectability.10-12 Access to derivatization reagents which react with AAs to form 
volatile derivatives has enabled the use of GC for measurement of D-AAs.11-13 Accordingly, GC 
has been used for D-AA measurements in tissues from a variety of animals, such as the turtle, 
harbor seal and wallaby, to name a few.12 One of the most notable results from GC analysis is the 
first measurement of D-Ser in the brain by Hashimoto and coworkers, where they measured 23% 
D-Ser in homogenate of telencephalon, diencephalon and midbrain from perfused rat brain.14 
Much like liquid chromatography, gas chromatography is another common separation 
technique. With this separation technique, the mobile phase employed is generally an inert gas, 
which is passed through a column. The inner surface of the column is the stationary phase for a 
gas chromatography separation; the stationary phase is typically a liquid or polymer coating. 
Because the analytes must be easily vaporized, gas chromatography applications are generally 
limited to volatile analytes. There are derivatization agents available to modulate the volatility of 
analytes to enable separation and measurement by gas chromatography.  
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Similar to the fluorogenic reagents used for AA analysis by separation techniques 
hyphenated with laser-induced fluorescence, the use of derivatization reagents for GC analysis 
introduces potential sources of error. As a specific example, the reaction of AAs with 
derivatization reagent pentafluoropropionic anhydride to form volatile derivatives (e.g. N(O)-
pentafluoropropionyl-(2)-propyl esters), involves harsher reaction conditions than the analogous 
reactions with common fluorogenic tags.13 Because the reaction with PFPA involves prolonged 
heating in the presence of hydrochloric acid, the derivatization introduces risks of chiral 
inversion and amino acid generation from protein degradation. With that said, some of these 
complications can be attenuated with appropriate sample pretreatment and experimental 
modifications. As an example, there are a number of LC-MS examples where use of deuterated 
strong acid negates the risk of confusing D-AAs produced from sample treatments with analyte 
originating from the sample.15-17 
A comparison of the capabilities of GC and LC for D-AA analysis reveals that GC is 
more sensitive, as demonstrated by the order of magnitude lower limits of detections for GC-
MS11 relative to LC-MS.4 The superior LODs for D-AAs by GC-MS places this technique in a 
position where D-AAs present in low abundance can more likely be observed. Some tradeoffs for 
analysis by GC include longer run times and more intensive sample preparation times, where 
hour-long sample treatments and analysis times are typical. As it is the case with LC, both chiral 
and achiral GC columns are available, enabling the researcher to utilize derivatization reagents 
which are achiral if preferred. Another commonality with many LC-based measurements is the 
use of derivatization reagents which react with common functional groups. This reality, in 
conjunction with the chemical complexity of biological samples, necessitates the use of ancillary 
approaches for confidence in the accuracy of chiral measurements. GC-based approaches will 
continue to be used for D-AA analysis, and improvements to detection capability, sample 
preparation and analysis times are anticipated. 
 
Capillary Electrophoresis (CE) 
Capillary electrophoresis is the final separation technique which will be discussed as a 
prominent D-AA measurement approach. In addition to proving useful for the measurement of D-
AAs in samples large enough for analysis by GC and LC (e.g. tissue homogenate), CE stands 
alone as a separation approach able to measure D-AAs in volume-limited samples such as single 
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cells and subcellular samples. Beyond amenability to low sample volumes, CE separations 
generally exhibit higher plate counts and shorter run times than LC and GC separations. The 
measurement of D-Ala in homogenate and stimulated release of pancreatic islets18 and the 
measurement of D-Ser in synaptic-like vesicles isolated from rat astroglial cells19 are among the 
noteworthy demonstrations of the capabilities of chiral CE. 
Similar to liquid chromatography, capillary electrophoresis is a liquid phase separation 
technique. Capillary electrophoresis utilizes the application of an electric field across a narrow-
bore capillary to achieve chemical separation. In traditional capillary electrophoresis separations, 
the application of an electric field results in analyte migration on the basis of electrophoretic 
mobility, which is related to charge and size. Analyte migration is also impacted by 
electroosmotic flow, which is produced when the inner surface of the capillary has a fixed 
charge. The resulting flow of the mobile phase exhibits a plug profile as opposed to a parabolic 
profile, as observed with pressure-driven flow, enabling narrower analyte peaks and higher 
separation efficiencies. Similar to other separation approaches, the researcher is granted 
flexibility with regard to mobile phase components, buffer additives, incorporation of a 
stationary phase and detection platforms.  
Although less commonly used for D-AA analysis than LC and GC, the performance 
characteristics of CE have solidified its position as the only separation option for D-AA 
measurement in volume-limited samples. In vivo measurement of D-Ser by online microdialysis 
coupled with CE has been demonstrated, made possible by the technique’s low mass detection 
limits and short analysis times.20 To date, CE is the only analytical approach which has been 
successfully employed for D-AA measurement in single cells and subcellular samples.21-24 The 
CE-based D-AA measurements to date have relied heavily on LIF detection, and accordingly 
involve the same advantages and caveats described previously approaches relying on analyte 
derivatization. With this potential for bias understood, CE results have often been supported with 
ancillary techniques (e.g. analysis by multiple techniques or analyte confirmation by enzymatic 
treatment).18,19,23  
Compared to LC and GC, two to three orders of magnitude less sample volume is loaded 
onto the capillary during traditional capillary electrophoresis experiments. With that said, sample 
amounts closer to what is used for LC and GC are sometimes used in large-volume sample 
stacking CE, which preconcentrates the sample prior to analysis.23 Another distinct different 
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between CE and the previously described separation techniques is the extent of flexibility 
granted to the user during method development and optimization. Specifically, the low cost of 
silica capillary paired with the vast selection of buffer constituents and separation additives 
enable many separation conditions to be rapidly screened with relative ease and without the 
restrictions of set column lengths, limited options for mobile phases and other limitations 
commonly encountered in LC and GC experiments, particularly when coupled with mass 
spectrometry. As CE is uniquely qualified for D-AA separations in volume-limited samples, 
continued application of the technique in the field is anticipated. As the field has seen with LC-
based analyses, coupling of CE with mass spectrometry and attempts to increase plexity are 
forecast as upcoming developments. 
 
Biosensors  
 “Biosensors” is an umbrella term for a vein of techniques which differ notably from the 
discussed separation techniques. The coupling of a biological component (e.g. enzyme, single 
strand of DNA) with a transducer (e.g. optical, electrochemical) enables the measurement of 
analytes which selectively interact with the biological component. There are a few examples of 
biosensors for D-AA measurement in biological samples.25,26 The enzymatic biosensor developed 
by the Mauzeroll lab used for measuring D-Ser involved coupling D-AAO (biological 
component) with a disk-shaped microelectrode (transducer).27 The resulting biosensor, with sub-
micromolar detection limits and a small footprint, provides a useful means of investigating D-
AAs in sample limited conditions as well as in vivo.  
Biosensors are well-positioned to measure D-AAs in conditions traditionally difficult to 
assay, particularly in vivo applications. Furthermore, biosensors are well-suited for continuous 
monitoring with a high degree of spatial and temporal resolution, which will prove useful for 
investigations focused on D-AA release and flux. Considering the short time-scale over which 
many biological processes can take place, the ability to make rapid measurements (< 1 second) is 
critical in order to capture dynamic changes. In vivo measurements of D-AAs by other techniques 
have not yet demonstrated the ability to work on such short timescales.  
In spite of the described strengths of biosensors, they have not been as extensively 
employed as the described separation approaches for D-AA measurement in biological samples. 
Perhaps the most critical complication with D-AA biosensors is susceptibility to cross-talk due to 
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the reliance on the degradative enzymes D-AAO and D-AspO. Both D-AAO and D-AspO have 
been shown to catalyze the degradation of a multitude of D-AAs. Consequently, the D-AAO/ D-
AspO-based biosensors cannot readily identify which D-AA(s) are generating the signal. The 
fabrication of these devices requires skill, can be time consuming and requires careful 
characterization to ensure reliable measurement. In spite of these challenges, developments 
addressing these crosstalk and accessibility are anticipated. Considering these performance 
characteristics and anticipated developments, in vivo measurements is expected to be a domain 
which will be largely dominated by biosensors.  
 
Histology 
The techniques discussed to this point are useful for the measurement of D-AAs, but are 
not well-suited to provide information on localization. In the case of LC and GC, the large 
sample requirements necessitate analysis of homogenate from large collections of cells – 
necessarily blending their analyte contributions together. Accordingly, LC and GC are poor 
options for experiments aimed at uncovering D-AA localization with a high degree of spatial 
resolution. Regarding single cell CE and small footprint biosensors, the limits on throughput 
make the task of uncovering localization patterns daunting. Consequently, histology remains the 
approach of choice for determining D-AA distribution with a high degree of sensitivity, 
specificity and spatial resolution.  
Histology is the field of studying the microscopic structure of biological samples (e.g. 
cells and tissues). This study of anatomy at the microscopic level is generally achieved through 
the visualization of stained or unstained specimens by optical, fluorescence or electron 
microscopy. Histological work very frequently involves the fixation of tissues to preserve a 
given specimen from degrading in such a way that the microanatomy is jeopardized. The use of 
selective stains facilitates the visualization and analysis of cells on the basis of cellular 
components (e.g. protein expression, chemical content).  
To this end, the field has relied heavily on immunohistochemistry to characterize 
localization. There are many examples where anti-D-AA antibodies have been applied for 
investigating D-Ser, D-Asp, D-Ala and D-Glu.9,28-37 Antibodies require epitopes larger than an 
individual amino acid, accordingly the anti-D-AA antibodies have been raised against the target 
D-AA linked to a carrier protein by a linker molecule. For example, the monoclonal antibody 
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used to visualize the localization of D-Ala in rat pancreas by Morikawa et al was raised against 
D-Ala linked to bovine serum albumin via glutaraldehyde and validated against cross-reactivity 
against the D- and L-forms of all the common amino acids as well as achiral glycine.30 
Additionally, in cases where D-AA-related proteins are known, their visualization can shed light 
on understanding D-AA involvement in a given tissue.3,7,9,31,33,34,36,38,39 The demonstration of the 
colocalization of serine racemase and insulin in the islets of Langerhans in both mice and 
humans is an excellent demonstration of an indirect analysis of D-AAs by histology.40 
Although immunohistochemistry is well-equipped for observing the distribution of D-
AAs with high spatial resolution, the approach involves fixation of the tissues prior to analysis. 
Unfortunately, this complicates the further characterization of the tissues with additional 
approaches. Accordingly, immunohistochemical analysis of D-AAs has largely been utilized to 
gain initial insights on localization and guide follow-up investigations focused on quantification 
or physiology. 
Another histological approach which has been leveraged in the study of D-AAs is enzyme 
histology. In 1985, Horiike et al. demonstrated the ability to visualize the localization of active 
D-AAO protein in tissue slices.33 The protocol cleverly leverages the hydrogen peroxide 
production of the D-AAO activity with horseradish peroxidase, 3,3'-diaminobenzidine (DAB) 
and nickel ions to reveal the localization of active D-AAO upon application of D-AAO-substrate 
(e.g. D-Ala or D-Pro). Sasabe and coworkers have advanced this enzyme histology approach to 
generate vivid images of D-AAO activity in various tissues.3,9 Although the generated images are 
not of the localization of the free D-AAs or the affiliated racemases or transaminases, the 
measurement of D-AAO distribution allows for indirect analysis of D-AAs as well as provides 
insights on aspects such as controlled degradation and signal termination. D-AAO enzyme 
histology has revealed a pronounced reduction in active D-AAO in the mouse model for 
amyotrophic lateral sclerosis (ALS).9 Extending this approach for the visualization of D-AspO is 
anticipated. An additional development which would prove useful would be modifying the 
protocol to visualize the D-AAs via application of recombinant D-AAO, D-AspO or engineered 
enzymes. Such a development of these histology and imaging variants would prove useful for a 





Overview and Outlook 
The diverse toolbox which has been assembled over the last several decades has enabled 
the measurement of D-AAs under a variety of contexts, such as in vivo measurement of D-Ser in 
rat brain,20 subcellular analysis of D-Asp in neuron processes from Aplysia californica,22 
localization of active D-AAO in rat brain slices,9 and profiling of a multitude of D-AAs in a 
variety of biological tissues and fluids.11,41 As measurement methodologies evolved, previously 
out-of-reach measurements have become attainable. The corresponding improvements in 
detection capabilities have led the way to additional discoveries. Many of the described 
approaches have matured to the point that sub-picomolar LODs,23 subcellular sample amount 
requirements,22 and in vivo measurement27,42,43 are growing increasingly accessible. As the field 
continues to characterize D-AAs and pursue functional studies, the drive for analytical 
development will persist. The development of multimodal methods to facilitate relating D-AAs 
levels with other analytes, refined approaches for sampling and auxiliary techniques for result 
validation are all on the horizon. Although it is difficult to forecast the intricacies of the 
developments to come, the current trajectory of the field suggests hyphenation of microscale 
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Introduction 
Aspartic acid (Asp), or 2-aminobutanedioic acid, is one of the non-essential 
proteinogenic (L-stereoisomer) endogenous α-amino acids. Of the common amino acids, Asp 
exhibits the lowest isoelectric point of 2.77. There are two conjugate bases for Asp, aspartate(1-) 
and aspartate(2-). As is true for most of the other proteinogenic amino acids, Asp has two 
enantiomers, an L-form and a D-form. The physical properties of both forms are identical, with 
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the exception of the direction the substance rotates plane-polarized light. Despite reports on the 
parameters of D-aspartate (D-Asp) as early as 1852,1,2 and the finding of the degradative enzyme 
D-aspartate oxidase (D-AspO) in rabbit kidney and liver in 1949,3 for more than a hundred years 
only L-aspartate (L-Asp) was considered as an endogenous form of Asp in animals. However, the 
detection of significant amounts of free D-Asp in the mollusk Octopus vulgaris in 19774 
challenged this view.  
Non-mammalian animal models are often used to investigate D-Asp involvement in the 
structural organization and functional activities of biological systems. This diverse group of 
organisms unites a variety of animal species—insects, mollusks, amphibians, reptiles and birds—
offering countless options for investigating the fundamental aspects of organismal function and 
evolution on different levels of organization, including cellular, tissue, organ, organismal and 
biota. For example, the mollusk Aplysia californica possesses a well-characterized neuronal 
network, allowing for the experimental determination of functional links between the activity of 
specific neurons and behavior. The insect Drosophila melanogaster and roundworm 
Caenorhabditis elegans have genomes and transcriptomes that are amenable to extensive 
molecular manipulation, as well as short life spans, making them ideal for high throughput 
investigations. These and other extensively characterized model systems make possible 
experiments that target diverse fundamental questions under controlled conditions. Not 
surprisingly, non-mammalian animal models have been widely used in D-Asp-related research to 
determine its localization, metabolism and function, as well as its role in cell-to-cell signaling.4-13 
D-Asp is one of several endogenous D-amino acids (D-AAs) found throughout the 
Metazoa. D-alanine (D-Ala), D-asparagine (D-Asn), D-serine, D-glutamate (D-Glu), and D-
glutamine (D-Gln) are also detected in different non-mammalian vertebrates and invertebrates, 
including cephalopods,4,5,14 gastropods,6-9 agnathans,15 amphibians,10,11 and reptiles.12,13 D-Asp 
has been detected in representatives from many phyla (for a review see16), including the 
roundworm C. elegans,17 the common cuttlefish Sepia officinalis,5 the Cape rock lobster Jasus 
lalandii,18 the amphioxus Branchiostoma lanceolatum,19 the sea squirt Ciona intestinalis,20,21 the 
edible frog Rana esculenta,10,11,22-24 the Italian wall lizard Podarcis s. sicula,25 the European hake 
Merluccius merluccius, the common sole Solea solea,26 and the chicken Gallus gallus 
domesticus.27 D-Asp has also been found in a variety of mammalian species. There are several 
recent reviews describing different aspects of D-Asp physiology, biochemistry and pathology in 
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mammals, an area of D-Asp research where investigations by Homma and his group have played 
a crucial role.28-37 
Detectable amounts of D-Asp are predominantly localized in the neuronal, endocrine and 
exocrine38 tissues and associated with cells producing significant amounts of secreted 
biochemicals, including cell-to-cell signaling molecules. For example, D-Asp has been found in 
the retina of octopus,39 as well as in the liver, kidney and brain of squid,14,39 frog,10,11,22,24,40,41 
neuroendocrine cells of the sea hare,8,42-45 and lizard.13,25,46,47 The tissue levels of free D-Asp 
typically increase in the earlier stages of an individual’s development and decrease with age.48 
The success of D-Asp research is partially due to progress in the development and 
application of a variety of analytical tools. One of the main challenges in the investigation of 
amino acid enantiomers is the similarity of most of their physicochemical properties. However, 
the difference in the shape of these molecules allows their chiral separation via affinity 
recognition or enzymatic transformation, enabling the detection and characterization of 
individual enantiomers. Utilization of complex approaches based on chiral high-performance 
liquid chromatography (LC)-laser induced fluorescence (LIF), capillary electrophoresis (CE)-
LIF and immunohistochemical staining, in conjunction with clever experimental designs such as 
radionuclide pulse-chase experiments and D-AspO sample treatment, have allowed the studies of 
D-Asp synthesis, uptake, localization and degradation with greater sensitivity, selectivity and 
confidence. Using these and other technologies, the roles of D-Asp in neurotransmission, 
neuromodulation and hormonal regulation have been investigated (for a review see30) and D-Asp 
neurotransmitter function has been asserted.14 The schematic in Figure 4.1 depicts 
experimentally suggested mechanisms reported to be involved in D-Asp neurotransmission, 
including D-Asp endogenous synthesis and known and putative transporters and receptors, as 
well as enzymes that are required for signal termination. 
We begin with a discussion of the development and implementation of analytical 
techniques used to investigate D-Asp, followed by information on D-Asp localization and 






Analytical techniques for D-Asp detection and characterization in biological 
systems 
The physical and chemical properties of L- and D-Asp are virtually identical, aside from 
the direction in which they rotate plane-polarized light. Therefore, D-Asp research requires 
methods that are capable of measuring enantiomeric species. A variety of suitable approaches 
based on enzymatic assays, affinity recognition and chiral separations, including CE and LC, 
have been introduced.49 Here, the emphasis will be on the more commonly employed methods 
for analysis of D-Asp in biological systems. 
 
Enzymatic assays 
Due to their ability to alter the structure of D-Asp with high selectivity, enzymatic assays, 
often using the enzymes D-AspO and D-amino-acid transaminase, are an effective approach for 
D-Asp analysis.4,5,50 For example, using a D-AspO-based colorimetric assay in which D-Asp was 
catabolized by D-AspO in the presence of flavin adenine dinucleotide, D'Aniello and Giuditta 
observed D-Asp in the nervous tissues of octopus and squid.4,5 This resulted in the formation of 
oxaloacetate, which was subsequently reacted with 2,4-dinitrophenylhydrazine to form a colored 
hydrazone compound, which was then quantified spectrophotometrically.51,52 Enzymatic 
approaches are typically not specific for a single D-AA, for example, D-AspO is known to also 
catabolize other D-AAs and derivatives of D-AAs, such as N-methyl- D-aspartate (NMDA), D-
Glu, D-Asn, and D-Gln. Typically, D-AspO exhibits different specificities for each substrate. 
Therefore, it is important to separate the D-AAs prior to enzymatic analysis to prevent signal 
overlap, thus enabling the characterization and quantification of individual species. 
 
Gas chromatography (GC) 
Due to the speed and resolving power of GC analysis, this rather mature separation 
technique has been widely used to separate amino acid enantiomers or their derivatives in 
complex mixtures. Chiral separations with GC are made possible by using columns where the 
common stationary phases are derivatized with compounds such as cyclodextrins (e.g., alkylated 
beta-cyclodextrins). Chiral columns in which D-AAs elute before their L-forms, and vice versa, 
are commercially available and can be used with optically inactive derivatization reagents to 
facilitate detection.53-56 Additionally, traditional achiral columns can separate diastereomers 
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formed by derivatization of D- and L-Asp with optically active reagents.57-59 However, it should 
be noted that derivatization with such reagents sometimes racemizes the amino acids.58  
Although there are a large number of detectors that can be utilized with GC, the flame 
ionization detector (FID) is one of the most widely used.53,54,57,58,60 More recently, the use of a 
mass spectrometer as a detector for GC, known as GC-mass spectrometry (MS), is an important 
approach. Compared to the FID, MS adds confidence to the analyte identification.55,56,59,61-64 
While providing an increased confidence in identification, it offers a poorer detectability 
compared to the FID; 300 nM is one example of GC-MS limits of detection (LOD) for D-Asp 
analysis.61 
 
Liquid chromatography (LC) 
Currently, LC is the most commonly used technique for D-AA analyses due to its 
versatility, robustness, flexibility and wide availability. As with GC, both chiral and achiral 
columns can be used. Chiral columns with stationary phases possessing optically active 
chemicals such as amino acids,65 crown ethers,66 cyclodextrins67 and proteins68 are used in the 
separation of intact enantiomers. For separations with achiral columns, D- and L-Asp must first 
be derivatized with chemical modifiers such as o-phthalaldehyde (OPA) and/or chiral thiols like 
N-acyl-L-cysteine to form diastereomers.17,69-73 Two-dimensional high performance LC 
separation using both achiral and chiral columns increases separation efficiency and simplifies 
analyte identification.74-76  
Analyses of D-Asp by LC typically utilize fluorescence or MS for detection. Fluorescence 
detection allows for quantification with high sensitivity, for example, an LOD of 150 nM was 
achieved for OPA-derivatized compounds77 and an LOD of 1 nM for 4-fluoro-7-
nitrobenzofurazan-modified molecules.76 Confidence in the identification of D-Asp in 
experiments relying on fluorescence-based detection can be enhanced by treating the sample 
with D-AspO, resulting in a specific decrease in the D-Asp peak area.9 Importantly, the use of MS 
detection adds information on the mass-to-charge ratios of the analytes. This information, along 
with retention time, aids analyte identification. The use of tandem MS (MS/MS) further 
enhances analyte identification capabilities.78 The reported LOD for MS/MS detection of D-Asp 




Capillary electrophoresis (CE) 
CE is yet another separation technique that has been used to analyze D-Asp in biological 
systems. This approach has a number of notable advantages, such as high separation efficiency, 
relatively short separation times and low sample volumes. As with LC and GC, there are chiral 
and achiral separation modalities available (reviewed in80). Chiral CE analyte separation, using 
micellar electrokinetic chromatography for example, utilizes the interaction between enantiomers 
and chiral pseudostationary phases, with cyclodextrin and its various derivatives80,81 most 
commonly employed as the chiral selectors. Chiral surfactants such as deoxycholate82 and N-
dodecoxycarbonylvaline83 are also capable of providing chiral separations in CE. The achiral 
separation is applicable in the analysis of diastereomeric derivatives of amino acids, which are 
produced by derivatization of analytes with optically pure reagents or chiral reagents like o-
phthaldialdehyde with N-acetyl-cysteine84 or chiral thiols.85 
LIF has been the most commonly utilized detection modality in CE analyses of D-Asp. 
Ultraviolet absorption86 and MS87,88 are also used for D-Asp detection following CE separation, 
although with significantly lower sensitivity. When LIF detection is employed, the sample is 
initially derivatized with fluorescent reagents such as fluorescein isothiocyanate89 and 
naphthalene-2,3-dicarboxaldehyde.90 The typical LODs in CE-LIF analyses of D-Asp are on the 
pM level, which are sufficient for even subcellular analyses.42 In addition to comparing 
migration times using standards and enzymatic (D-AspO) treatments,  immunoprecipitation of D-
Asp increases the confidence in the D-Asp measurements.91  
 
Immunohistochemistry 
The previously described enzymatic assays, GC, LC and CE, are useful for the 
characterization and quantification of endogenous free D-Asp; however, they do not allow for the 
determination of D-Asp's distribution in a given system with high spatial resolution. In cases 
where details on analyte distribution are needed with high specificity, sensitivity and spatial 
resolution, immunohistochemical staining is the method of choice. With proper tissue sample 
acquisition and fixation, and treatment with a selective antibody, information on the localization 
of D-Asp can be acquired. Accordingly, to enable the direct immunohistochemical analysis of D-
Asp, selective anti- D-Asp antibodies have been developed using the glutaraldehyde conjugate of 
D-Asp as an antigen.92-94 The obtained antibodies exhibit specificity only to the glutaraldehyde 
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conjugate of D-Asp, and not to that of L-Asp, thus enabling specific immunohistochemical 
staining after tissue treatment with glutaraldehyde. The successful application and efficacy of the 
developed antibodies for the purpose of D-Asp visualization is shown in Figure 4.2, which 
depicts immunostained neurons from Aplysia limacina showing differences in D-Asp localization 
from cell to cell. Specifically, the intensity of D-Asp immunostaining is distinct in the nucleus 
and the cytoplasm of different neurons, suggesting a unique function of D-Asp in different 
neuronal populations.  
 
Indirect detection approaches 
The presence of D-Asp in a biological system can be inferred based on the presence of 
metabolic enzymes that are related to D-Asp, such as D-AspO and D-Asp racemase. These 
proteins can be detected with the use of affinity probes, which are commonly used in 
immunohistochemistry and related approaches such as immunoelectron microscopy, and using 
Western blotting and a range of molecular reporters such as protein coexpression with green 
fluorescent protein.45,95-98 These approaches are used to localize D-Asp related proteins, and 
hence indirectly, the presence of D-Asp itself.   
 
D-Asp localization, metabolism and fluxes 
The application of the approaches described above have facilitated significant progress in 
characterizing and understanding the metabolism, concentration fluxes and functions of D-Asp in 
neuronal, endocrine and exocrine tissues. Information on the localization, fluxes and levels of a 
given analyte in cells, tissues and organs provides important clues on its putative function as well 
as its relation to various pathological states. The multiple mechanisms of D-Asp synthesis, 
uptake, spatial containment, release and catabolism, as well as the different modes of regulation 
of extracellular and intracellular D-Asp levels, indicate that this molecule is an important player 
in the homeostatic balance of multicellular organisms.29 These mechanisms also suggest the 







Localization of D-Asp 
Investigations of D-Asp localization have been carried out on vertebrate22,25 and 
invertebrate39,44 models as well as on cell cultures.99-101 These studies often involved 
immunohistochemical staining with anti- D-Asp antibodies in order to visualize D-Asp 
localization in cells and tissues, as well as used a variety of analytical techniques to detect the 
presence of endogenous and  radiolabeled D-Asp. Using these approaches, D-Asp has been 
detected in a large number of nervous, exocrine and endocrine tissues of non-mammalian 
animals, including the gonads and Harderian glands of tiger prawn Penaeus esculentus10,22,23 and 
the lizard P. s. sicula,46,47 as well as the central nervous system of sea hare44 and green frog.41 Di 
Fiore et al. (2014) reviewed and summarized reports of D-Asp concentrations in endocrine and 
exocrine glands of several different species. Endogenous D-Asp concentrations in the exocrine 
Harderian glands of frog and lizard are 130 and 19 nmol/g tissue, respectively. Levels of D-Asp 
in endocrine glands are often similar to concentrations of the compound in exocrine glands. As 
examples (all in nmol/g tissue): the adrenal glands of chicken (23–30), pancreas of pigeon (15–
18), chicken (6–10), frog (3–58), duck (11–23), and lizard (2–8 in ovaries and 3–30 in testes). 
Frog testes exhibit the highest levels of D-Asp at 140–236 nmol/g. D-Asp levels in the above-
mentioned glands are in the same concentration range as in the exocrine and endocrine glands of 
mammals, except for the rat pineal gland where its concentration may reach 3524 nmol/g tissue. 
Importantly, D-Asp concentrations in these glands may vary with age and functional state, as 
well as with the levels of D-Asp in the extracellular environment. 
Free D-Asp formation and accumulation generally occur in a site-specific manner. For 
example, D-Asp was detected in the brain optic lobe of the cephalopod,39 suggesting it may play 
a role in cephalopod vision. The detected D-Asp most likely had an endogenous origin. In other 
studies, D-Asp was found to form and accumulate in specific A. californica ganglia44 and in the 
somata of selected neurons.14 
 
Biosynthesis of D-Asp 
There are several sources of D-Asp in organisms.  Exogenous sources include the 
environment; e.g., seawater,102 food,103,104 and gut microbiota,105 whereas the endogenous 
sources are due to enzymatic conversion of L-Asp to D-Asp and the freeing of D-Asp from D-AA-
containing proteins. D-AA residues of proteins are formed via enzymatic106 and 
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nonenzymatic107,108 processes, which are often age-dependent. The exogenous origin of some D-
Asp is supported by results of experiments carried out in both mammalian and non-mammalian 
animals, which have demonstrated the absorption of this small molecule by the intestine and its 
transport to various solid tissues, including the brain, muscle, kidney and liver.109 The enzymatic 
conversion of L- to D-Asp has been shown in a number of models, including pheochromocytoma 
cells110 The use of radiolabeled L-Asp in pharmacological, biological and analytical studies has 
demonstrated that  D-Asp can be formed from L-Asp via enzymatic activity in the nervous 
system, as shown in Figure 3.44 This observation corroborates findings of other studies 
performed on invertebrates such as European squid Loligo vulgaris14,39 and sea hare A. 
californica8 as well as vertebrates, e.g., the Italian wall lizard P. s. sicula46,47 and the edible frog 
Pelophylax esculentus.23,24 
In light of the findings from the aforementioned studies, it has been hypothesized that in 
non-mammalian animals, D-Asp is synthesized by enzymes with characteristics similar to known 
racemases and by D-AA aminotransferases. One such D-Asp racemase has been cloned from the 
foot muscle of the clam Anadara broughtonii and subsequently purified and characterized.7,111 
More recently, two pyridoxal-5’-phosphate-dependent D-Asp racemases were reported and 
characterized, one from the mouse brain 98. The other was from the head ganglia of A. 
californica;45 interestingly, this D-Asp racemase was found to also catalyze serine racemization.  
In addition to D-Asp racemases, free D-Asp can be produced during the enzymatic 
degradation of D-AA-containing peptides and proteins, perhaps where D-aspartyl endopeptidase 
(EC 3.4.99.B2) plays a role. D-AA-containing peptides are typically formed by age-dependent 
posttranslational deamidation, isomerization and racemization of L-aspartyl residues.32,112,113 As 
result, D-aspartyl, and D-isoaspartyl residues are produced. While this mechanism may be 
responsible for only a small percentage of free D-Asp, it can impact D-Asp levels in some tissues 
and cells.  
 
Catabolism of D-Asp 
In addition to its formation, the ability to remove or degrade D-Asp is also important. For 
example, the catabolism of intercellular signals allows for signal termination and preparation for 
a new signaling event. D-Asp clearance combines diffusion away from the site of release, uptake 
by neurons or glia, and/or enzymatic modification, including breakdown. D-Asp catabolism is 
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predominantly mediated by the enzyme D-AspO, a flavoenzyme which selectively catalyzes the 
oxidation of D-Asp, D-Glu and NMDA to their corresponding α-ketoacids.109 In contrast, the 
oxidative transformation of neutral and basic D-AAs into α-ketoacids is carried out by a different 
flavoenzyme, D-amino acid oxidase (D-AAO). Both D-AspO and D-AAO are reported in C. 
elegans17,114 and L. vulgaris,14 and are likely ubiquitous throughout the Metazoa. Interesting 
distributions of these enzymes occur; for example, D-AspO is present in higher concentrations in 
L. vulgaris brain cytosol fractions.  
D-AspOs from different species exhibit a variety of catalytic efficiencies. For example, 
multiple genes encoding functional D-AspOs have been found in C. elegans, each with unique 
specificities, kinetic parameters and expected subcellular localizations.114 Although the 
physiological functions of the multiple D-AspOs may be redundant, the aforementioned 
differences in compartmentalization, concentration and catalytic properties suggest the 
possibility of distinct roles for each enzyme. It is apparent that the existence of multiple D-AspOs 
with functional differences can allow for the modulation of local concentrations of D-Asp and 
thereby play integral roles in signaling, possibly by attenuating or terminating D-Asp signaling 
via its degradation. 
Hypothetically, two other enzymes could influence the levels of free D-Asp. One is the 
protein- L-isoaspartate (D-aspartate) O-methyltransferase (EC 2.1.1.77), which is involved in the 
repair of age-related damage of protein aspartate and asparagine residues.115 Another enzyme, D-
amino acid transaminase (EC 2.6.1.21), catalyzes reactions in which D-Ala and D-Glu are formed 
from D-Asp. However, so far, the presence of this enzyme has only been reported in 
microorganisms and plants, e.g., Arabidopsis thaliana.116  
The important role of D-AspO in the oxidative degradation of D-Asp as a consequence of 
its potential involvement in signaling pathways has led to investigations of the relationship 
between D-Asp levels and D-AspO activity in non-mammalian species. For example, 
intraperitoneal injection of D-Asp into green frog led to an increase of D-AspO activity in a 
variety of organs: brain, kidney, liver, pancreas, Harderian gland, heart, spleen and testes.22,40 In 
contrast, no increase in D-AAO or L-amino acid oxidase activities were observed following D-
Asp administration.22  
These data demonstrate that D-AspO may have multiple physiological purposes. It is 
possible that D-AspO is responsible for the general metabolism of endogenous and exogenous D-
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Asp to prevent the accumulation of high concentrations of D-Asp, which may have a negative 
impact on normal functioning of biological systems. Additionally, D-AspO may also be involved 
in the controlled degradation of D-Asp for the purposes of chemical signaling modulation, 
including signal termination. 
 
D-Asp Flux  
Understanding the movement of D-Asp into and out of specific locations, its flux, is 
important.  Amino acid transporters such as solute carrier family 1 members 1-5 (also reported as 
excitatory amino acid transporters 1-5 (EAATs 1-5)) likely are involved in its import mediated 
by the Na+/K+ electrochemical gradient (for reviews see117-119). For example, dEAAT1 and 
dEAAT2 are present in the nervous system of D. melanogaster;120,121 see Figure 4.4. Drosophila 
sodium-dependent high-affinity aspartate transporter dEAAT2 has a much lower affinity to 
glutamate than D- or L-Asp. In another example, a single EAAT was expressed in the neuropil 
regions of the thoracic ganglia of the mosquito Aedes aegypti.120 The transporter mediates high 
affinity uptake of D-Asp as well as L-Asp and L-Glu, where both of the L-amino acids compete 
with D-Asp uptake. Therefore, the resulting excitatory amino acid import will depend on the 
extent and profile of transporter expression as well as levels of these compounds in the 
extracellular space, where D-Asp is typically present at lower concentrations. Not surprisingly, a 
large body of information on D-Asp transmembrane transport is available for mammalian models 
(for reviews see122,123). This knowledge can be used in genomic and transcriptomic searches to 
aid the identification of molecular homologs in non-mammalian species. 
D-Asp can be transported along nerves to release sites8,14,44 and subsequently released 
upon stimulation. The vesicular nature of D-Asp release is also supported by the measurement of 
the subcellular localization of D-Asp in synaptosomes and synaptic vesicles of the nervous 
systems of A. limacina9 and L. vulgaris.14 Along with D-Asp, these synaptic vesicles possess 
relatively high levels of L-Asp and L-Glu, creating competitive conditions for neurotransmitter 
import by EAATs.  
 
Physiological functions of free D-Asp   
A number of roles for free D-Asp in central physiological processes on the cellular, 
tissue, organ and organismal level have been suggested, and in some cases, experimentally 
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confirmed. A large number of reports point to D-Asp operating as an environmental signal, 
neuromodulator, hormone and neurotransmitter, and being involved in mechanisms of the 
biosynthesis of hormones, endocrine and exocrine secretion,124 neurogenesis, memory,125 
reproduction, vision, individual development and stress.126  
 
Neuronal function 
In neurons, D-Asp may generate an immediate cellular electrophysiological response 
through activation of the N-methyl- D-aspartate receptor (NMDAR), a type of ionotropic 
glutamate receptor,127 NMDAR-like receptors,128 or sodium-dependent EAATs. The presence of 
other or unknown receptors and/or transporters that are specific to D-Asp is indicated by results 
of experiments where 25% of studied A. californica neurons exhibited D-Asp-induced currents 
but were not sensitive to L-Glu application.128 Similarly, noticeable specificity to D-Asp is 
characteristic of Drosophila sodium-dependent dEAAT2121 (Figure 4.4). Indeed, partial 
involvement of EAATs in the formation of D-Asp-induced L-Glu-independent cation currents in 
cultured A. californica neurons was demonstrated using a transporter blocker.129  
The involvement of NMDA-receptors in D-Asp-induced physiological and behavior 
effects is supported by the results of experiments involving systemic in vivo 
intracerebroventricular administration of D-Asp to neonatal chicks. Specifically, when subjected 
to stressful conditions, D-Asp dose-dependent calming of the animals was observed, including a 
decrease in vocalization and an increase in the duration of time spent in resting positions with 
eyes open.126 NMDA injection was also found to yield sedative effects.130 The effects of L-Asp 
mimicked those of D-Asp; however, the periods of sleep-like state were observed to be longer, 
indicating possible mechanistic differences for the two enantiomers.   
 
Environmental signals 
Decapod crustaceans such as the red rock crab (Cancer productus) and the Pacific rock 
crab (Romaleon antennarium) possess chemoreceptors located at their claw’s moveable fingers, 
or dactyls. Application of D-Asp induced an almost five times higher electrophysiological 
response in the corresponding nerve than application of L-Asp.131 Importantly, the response to D-
Asp is pH-dependent and not visibly modulated by the presence of L-Asp. It is plausible that D-
Asp is present in sea water at nM concentrations; for example, the top layer of the ocean near 
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Hawaii has been found to contain 8 nM of total dissolved D-Asp.132 This makes it apparent that 
D-Asp, along with other amino acids, may work as an environmental signal for marine animals. 
In the ocean environment bacterioplankton are considered the main biotic source of D-Asp, and 
some other D-AAs, and are found in the cell walls of these microorganisms.102,133  
 
Organism development 
D-Asp has been shown to play a role in development. In an early study, a transient 
increase in D-Asp levels during the embryonic stage in chicken was detected, with maximal 
concentration in the retina and brain between the 10th and 15th day of incubation.48 D-Asp in the 
chicken retina was observed to reach 20% of the total Asp levels at day 13. No similar changes 
in D-Asp content were found to occur in the heart, muscle and liver during this stage of organism 
development. Additionally, C. elegans demonstrate a transient increase in D-Asp content, with a 
maximum level at the L3 larva stage.17 Interestingly, there is strong evidence to suggest that 
expression of the excitatory amino acid transporters dEAAT1 and dEAAT2 leads to formation of 
glia in the embryonic Drosophila central nervous system, and may be involved in the generation 
of the functional diversity of these glial cells.134 The temporal alignment of such events may be 
significant for proper development of nervous system cellular circuitry. 
 
Reproduction 
The high concentration of D-Asp observed in the testes and ovaries of various non-
mammalian animals suggests an involvement in reproduction.10,11,23 Quantitative measurements 
of free D-Asp in the seasonal breeding green frog and Italian wall lizard uncovered a correlation 
between D-Asp levels and the phases of the reproductive cycle11 (Figure 5). Moreover, D-Asp 
levels were found to correlate with androgen production in a sex- and species-dependent manner. 
D-Asp application in vivo enhanced expression of P450 aromatase mRNA and protein levels in 
male frog brain, which led to an increase in 17β-estradiol synthesis as well as a corresponding 
increase in expression of its receptor.135 The modulatory effects of P450 aromatase expression 
were found to be a result of D-Asp participation in the CREB pathway. In a separate experiment, 
a D-Asp intraperitoneal injection was observed to modulate the levels of testosterone and 17β-
estradiol in Italian wall lizard.46,94 The data made evident that D-Asp regulates steroidogenesis 
and spermatogenesis. The observed involvement of D-Asp in reproduction in a number of 
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different species suggests that this particular functional role of D-Asp is likely evolutionarily 
conserved. For example, C. elegans has three functional D-AspOs: D-AspO-1, D-AspO-2 and D-
AspO-3.114 Modulation of D-AspO-1 expression alters D-Asp levels in animals, which correlates 
with changes in egg-laying capacity as well as hatching rate.17  
 
Vision  
As mentioned earlier, another physiological function in which D-Asp may play a role 
relates to vision. This potential role for D-Asp is supported by its abundance in the retina of 
multiple animals, including the chicken48 and common cuttlefish.39 D-Asp was also found to be 
present in the optic lobe of S. officinalis.39 There are several origins of D-Asp in the retina of this 
animal, including transport from the optical lobe as well as endogenous synthesis by the action of 
D-Asp racemase. The levels of D-Asp, L-Asp, L-Glu, and D-Asp racemase all decrease in both the 
retina and optic lobe after sustained light deprivation. However, other amino acids exhibit no 
change with regard to concentration. These observations strongly point towards an important role 
for D-Asp in vision.  
 
Summary 
D-Asp has been an enigmatic molecule throughout the Metazoa, with a number of studies 
helping to define its formation, localization and degradation. Uncovering the different roles of D-
Asp has been possible by the development and application of a number of measurement 
approaches that provide information on the specific chiral form of Asp in an animal tissue. The 
measurement approaches have included immunohistochemical staining, LC-LIF and CE-LIF.  
Now that such approaches exist, studies have turned to more functional questions. The 
use of non-mammalian animal models has enabled the characterization of D-Asp in organisms 
with well-understood nervous systems, such as A. californica, and in organisms with short life 
spans and well-characterized genomes, such as C. elegans. The result of the D-Asp research has 
been the thorough investigation of the biosynthesis, localization, metabolism, controlled 
degradation and concentration fluxes of this D-AA. Together these findings provide a more 
complete understanding of free D-Asp and its involvement in important physiological processes, 
from the cellular to the organismal level. For example, the cell to cell signaling roles of free D-
Asp have been demonstrated in a number of non-mammalian animals. In addition, several 
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physiological and behavioral effects have been linked to D-Asp. Specifically, relationships to 
cell-to-cell and environment-to-organism signaling, as well as neurogenesis, reproduction and 



































Figure 4.1: Schematic of potential D-Asp involvement in synaptic signaling. Biosynthesis of D-
Asp from L-Asp in cell soma by the action of aspartate racemase, release from presynaptic 
terminals, and interactions with receptors and transporters are depicted. Additionally, D-Asp 
involvement in signal transduction through triggering of an increase in cyclic adenosine 
monophosphate (cAMP) concentration in a postsynaptic neuron and signal termination via the D-












Figure 4.2: Paraffin section of a cerebral ganglion from Aplysia limacina immunostained with 
anti-D-Asp antibody. Immunohistochemical staining visualized the differential localization of D-
Asp; some cells are stained in the (1) nucleus, others in the (2) cytoplasm, and others still in both 
the (3) cytoplasm and nucleus, and positive staining is also observed in the (arrows) neuropil 











Figure 4.3: Biosynthesis of D-Asp in a cerebral ganglion of Aplysia californica. (a) Final 
percentages of radiolabeled Asp enantiomers after incubation of intact cerebral ganglion in [14C]-
L-Asp, showing biosynthesis of D-Asp from L-Asp. (b) Final percentages of radiolabeled Asp 
enantiomers after incubation of desheathed cerebral hemiganglia and related sheath tissue in (1) 
[14C]-L-Asp and (2) [14C]-L-Asp, showing significantly larger conversion of [14C]-L-Asp to 
[14C]-D-Asp in the hemiganglion over the sheath tissue (Reprinted with permission from Scanlan 











Figure 4.4: Central nervous system expression patterns and transport properties of Drosophila 
melanogaster excitatory amino acid transporters (EAATs). Left panels: ventral views of 
Drosophila embryos stained with in situ hybridization with antisense (a) dEAAT1 or (b) dEAAT2 
RNA probe. A differential expression pattern for dEAAT1 and dEAAT2 is apparent, with 
substantially higher expression levels for dEAAT1 in the embryonic nerve. Right panels: uptake 
of radiolabeled L-Glu and D-Asp into Drosophila S2 cells transfected with (a) dEAAT1 or (b) 
dEAAT2 cDNAs. Cells were transfected with (white bars, control) mock plasmid or (gray bars) 
Drosophila EAAT expression vectors. Selective transport of D-Asp relative to L-Glu is apparent 
for dEAAT2, whereas dEAAT1 shows comparable transport for the two excitatory amino acids 




Figure 4.5: Free D-Asp is present in the ovary extract of Rana esculenta in each phase of the 
sexual cycle. The variations in D-Asp concentration depend on the phase of the reproductive 
cycle, with the highest D-Asp concentrations observed during the prereproductive period, at 
which time testosterone is at its minimum level. During the reproduction phase, D-Asp 
concentration decreases substantially, while the testosterone levels in the ovary and plasma 
increase greatly. During the post-reproductive period, the concentration of D-Asp moderately 
increases relative to the reproductive period, and the ovarian and plasma testosterone levels 
reduce to moderately low concentrations (Modified with permission from Raucci and Di Fiore 
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This chapter described the development of a chiral capillary electrophoresis method 
which employs online sample preconcentration. The evaluation of the technique’s performance is 
also discussed. Additionally, the findings from application of the developed approach for the 
measurement of D-aspartate and D-glutamate in individual neurons isolated from the Aplysia 
californica central nervous system are described. This chapter is adapted from a completed 
manuscript written with coauthors T. Kawai, L. Wang, S. S. Rubakhin, and J. V. Sweedler, 
published on October 24th, 2017. Adapted with permission from Analytical Chemistry, 2017, 89 
(22), pp 12375–12382, DOI: 10.1021/acs.analchem.7b03435. Copyright 2017 American 
Chemical Society. T. Kawai contributed towards initial method development, L. Wang 
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Introduction 
Amino acids are an important class of small molecules that are critical for organismal 
function. Specifically, they are involved in cell-to-cell signaling and metabolism, and play a 
structural role as the building blocks of peptides and proteins.1 With the exception of glycine, 
amino acids are chiral molecules and can be found in either the D- or L-form. In the context of 
higher animals, it was generally accepted that only the L-form was the physiologically relevant 




 Following their discovery, numerous investigations of D-AAs have been carried out in 
invertebrate and vertebrate animal models. Notable non-mammalian examples include Loligo 
vulgaris,3,5,6 Pelophylax esculentus (formerly Rana esculenta),7-10 and Aplysia californica.11,12 
Research also been performed in mammals, such as the rat,4,13-16 as well as in humans.17-19 These 
studies have demonstrated the presence, and often the physiological importance, of different D-
AAs.  
 Among these, D-serine (D-Ser) and D-aspartate (D-Asp) have been the most extensively 
studied. Functioning as a transmitter, D-Ser is an endogenous agonist for the N-methyl-D-
aspartate (NMDA) receptor in different brain regions. Its misregulation is associated with 
schizophrenia and depression.15,20-22 D-Asp exhibits all of the characteristics required for a 
neurotransmitter and/or neuromodulator.6,11,23-26 Also, D-Asp has been associated with 
physiological processes such as neurogenesis,27 reproduction,9,19,25,28 and vision.5 Despite the 
progress in understanding the endogenous roles of D-Ser and D-Asp, more work is required to 
better characterize their participation in numerous cell-to-cell signaling pathways, as well as their 
overall functional significance.  
 A number of other D-AAs have been detected in animals, but their biological functions 
remain poorly characterized.29-31 For example, the functional roles of D-glutamate (D-Glu) 
remain enigmatic, despite its presence in various brain and peripheral tissues of the mouse,31 in 
the brain, kidney, and liver of the rat,32,33 the retina of multiple mollusks,5 and throughout the 
nervous system of Aplysia limacina.26 It appears that one limitation on the functional 
characterization of D-Glu relates to challenges associated with its measurement. It was recently 
reported that D-Glu was the only D-AA not found at detectable amounts in the mouse brain.34  
 Beyond its presence in biological tissues from a variety of animals, D-Glu may 
accumulate in rat synaptic vesicles, bind to NMDA receptors, and induce excitotoxicity.35 
Accumulation of D-Glu in the rat retina has also been reported.36 Application of D-Glu was 
shown to cause muscle contraction in Bombyx mori,37 as well as induce a rise in intracellular 
Ca2+ in muscle cells from Pleurobrachia bachei and Bolinopsis infundibulum.38 Moreover, 
enzymes capable of catalyzing the degradation of D-Glu, D-glutamate cyclase, and D-aspartate 
oxidase (D-AspO), have been identified across the metazoa.8,31,39-44 How is D-Glu synthesized? 
Although there are no well-characterized glutamate racemases, a recent study demonstrated 
glutamate racemase activity with known aspartate racemase enzymes from Panaeus monodon 
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and Crassostrea gigas.45 Interestingly, the murine glutamate-oxaloacetate transaminase 1-like 1 
(GOT1L1), which was reported as an aspartate racemase, also exhibited dual racemase activity 
by synthesizing D-Glu in addition to D-Asp.27 Follow-up work on rat and human homologs of 
GOT1L1 suggest it may not be the mammalian source of D-Asp.46   
 Measurement of D-AAs in animal tissues has largely been carried out via chiral liquid 
chromatography (LC) paired with detection by laser-induced fluorescence (LIF) or mass 
spectrometry (MS).30,47-51 Though robust and successfully applied to the study of many different 
D-AAs in tissues from a broad range of animals, LC-based approaches are not as well suited for 
measuring volume-limited samples. Enzymatic biosensors have been shown to be useful for 
some such volume-limited measurements.52 With regard to D-AA analyses at single cell and 
subcellular levels, these have been largely accomplished with chiral capillary electrophoresis 
(CE) paired with LIF detection.11,53,54 
 The limited progress on the characterization of a number of D-AAs in single cells is 
partly due to the analytical challenges of chiral single cell analyses. In addition to the difficulties 
associated with most chemical assays of biological material, such as biofouling or system peak 
interference, analyses of D-AAs are further complicated by their low endogenous concentrations 
and heterogeneous distribution. Therefore, measurement of D-AAs at the single cell level 
requires the implementation of methodologies that can work with limited sample volumes, 
overcome sample matrix effects, and discriminate analytes on the basis of chirality with low 
limits of detection. 
 To address these challenges, we developed a variant of large-volume sample stacking 
(LVSS) chiral CE-LIF. There are a large number of characterization approaches for online 
preconcentration of analytes used in CE, often uniquely tailored for a given set of analytes. The 
wide variety of sample stacking approaches, as well as their mechanisms and applications, have 
been well reviewed.55-58 The LVSS-CE-LIF approach described here afforded over two orders of 
magnitude signal enhancement and enabled analyses of D- and L-Asp, as well as D- and L-Glu, in 
single A. californica neurons. We observed differences in the amounts of the well characterized 







Materials and Chemicals  
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless stated otherwise. 
Aqueous solutions were prepared with ultrapure deionized (DI) water from an ELGA Purelab 
Ultra water system (USFilter, Lowell, MA). Phosphate buffer saline (PBS) was purchased from 
Mediatech (Manassas, VA). Amino acids were stored as neat aqueous solutions at 14 °C. 
Naphthalene-2,3-dicarboxaldehyde (NDA) was purchased from Invitrogen (Carlsbad, CA). For 
the CE separations, 2-(N-morpholino)ethanesulfonic acid (MES), potassium bromide (KBr), and 
quaternary ammonium β-cyclodextrin (QAβCD) (CTD Holdings, Alachua, FL) were used. For 
D-Asp peak confirmation by enzymatic degradation via D-AspO, flavin adenine dinucleotide 
(FAD) and catalase (10,000–40,000 U/mg protein, 34 mg protein/mL suspension) from bovine 
liver were prepared in PBS. Homemade desalting tips were loaded with polymer slugs punched 




A. californica were obtained from the Aplysia resource facility (University of Miami, 
Miami, FL), maintained in an aquarium with continuously circulating aerated and filtered sea 
water (Instant Ocean, Aquarium Systems Inc., Mentor, OH) at 14–15 °C until used. Animals for 
the single cell measurements weighed 125–200 g. For whole F-cluster measurements, animals 
weighed 5–20, 70–80 and 150–230 g for the juvenile, small adult, and large adult samples, 
respectively. Animals were anesthetized by injection of isotonic MgCl2 (~30 to ~50% of body 
weight) into the body cavity. The cerebral ganglia were dissected and placed in artificial sea 
water (ASW) containing (in mM): 460 NaCl, 10 KCl, 10 CaCl2, 22 MgCl2, 6 MgSO4, and 10 
HEPES (pH 7.8), or in ASW-antibiotic solution (ASW supplemented with 100 units/mL 
penicillin G, 100 μg/mL streptomycin, and 100 μg/mL gentamicin, pH 7.8). To facilitate 
mechanical isolation of cellular clusters and individual neurons, the ganglion sheath was digested 
enzymatically by incubation in 1% protease (Type IX: Bacterial) ASW-antibiotic solution at 34 
°C for 40–90 min, depending on animal size and season. Isolated ganglia, cellular clusters, and 
cells were washed in fresh ASW. 
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 Each isolated cell was separately placed in 100 µL of methanol, sonicated for 10 min at 
20 °C, and then centrifuged at 9000 g for 5 min. Thereafter, the supernatant was collected and 
then dried with a Savant SpeedVac concentrator (Thermo, Milford, MA). All samples were 
reconstituted in DI water. 
 
Sample Derivatization and Desalting 
Derivatization procedures for the standards and samples for LIF detection were 
accomplished by mixing the aqueous standard mixture or sample with NDA (20 mM in 
acetonitrile (ACN)) and potassium cyanide (KCN) (saturated in ACN, 20 °C) in a 1:1:2 ratio. 
Mixing was achieved with pipetting and the reaction was allowed to proceed for one hour in the 
dark at 20–24 °C. SAFETY NOTE: our NDA reaction protocol involves the use of unbuffered 
KCN and should be carried out in a fume hood while following safety procedures to minimize 
risk of cyanide exposure. Alternative reaction protocols can also be considered.  
 Following derivatization, each reaction mixture was dried under vacuum, reconstituted in 
DI water, and desalted by homemade centrifuge extraction tips.59 In brief, SPE columns were 
constructed by loading 0.7–0.8 mg of polystyrene-divinylbenzene into a 200 µL pipette tip. Next, 
the SPE polymer bed material was activated with pure ACN, conditioned with water, loaded with 
a reaction mixture in minimum volume, desalted with 10 µL water, and analytes eluted with 20 
µL pure ACN. Finally, each eluted, desalted sample was quickly dried under vacuum and 
reconstituted in DI water. 
 In order to confirm the presence of D-Asp, we treated some samples with D-AspO; thus, 
several amino acid standards and single cell extracts were mixed with D-AspO (4.6 mg/mL), 
FAD (5 mM), and catalase (68 µg/mL) in a 1:0.6:1:1 volume ratio. Next, the mixture was 
incubated in a water bath at 37 °C for 5.75 h. Each enzyme-treated sample was dried and 
reconstituted in 1 µL of water prior to derivatization, desalting, and analysis by CE-LIF. 
 
Capillary Zone Electrophoresis (CZE)-LIF 
Separations were performed with a PA 800 plus Pharmaceutical Analysis System with 
LIF detection (AB SCIEX, Framingham, MA). This system was coupled to an external diode 
laser (56ICS426, Melles Griot, Carlsbad, CA) with a fiber optic cable (OZ Optics, Ottawa, ON, 
Canada).  The laser was operated at 3 mW with an emission wavelength of 440 ± 8 nm. The LIF 
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detection module was modified with a 490 ± 15 nm band-pass filter (Omega Optical, 




Buffer solutions were prepared in DI water to avoid impurities and minimize 
conductivity. We prepared 250 mL of 280 mM MES buffer (pH 6.00) by dissolving 14.7 g of 
MES hydrate (4.7% H2O) in 200 mL of DI water, adjusting pH with 1.0 M NaOH, and then 
diluting to volume with DI water. A 10% (w/v) QAβCD solution was prepared by dissolving 
0.0790 g of QAβCD in 0.790 mL of DI water. Additionally, we prepared 200 mM KBr by 
dissolving 2.39 g of KBr into 100 mL of DI water. The separation buffer with final 
concentrations of 60 mM MES (pH 6), 10 mM KBr, and 110 ppm QAβCD, was prepared daily 
by mixing appropriate amounts of each component and DI water. Prior to use, buffers were 
degassed by sonication. Bare fused-silica capillaries (Polymicro Technologies, Phoenix, AZ) 
were used for all separations. The total/effective lengths of the capillaries were 50/40 cm, with 
inner/outer diameters of 50/360 µm. All capillaries were treated with 0.1 M NaOH for 30 min 
prior to initial use. Further, all capillaries were sequentially rinsed with 0.1 M NaOH, DI water, 
and separation buffer for one min prior to each analysis. The separation buffer was replenished 
prior to each separation. Whole capillary volume sample injection was performed 
hydrodynamically with a pressure of 20.0 psi for one min. For both the LVSS and CZE 
separation methods, the voltage and temperature were -26 kV and 18 °C respectively. OriginPro 
2015 software (Origin Lab Corp., Northampton, MA) was used for data analysis.   
 
D-Aspartate Oxidase Cloning and Purification 
Mouse kidney D-aspartate oxidase (D-AspO) was cloned by a reverse transcription 
polymerase chain reaction (RT-PCR) technique and produced as Histagged protein in 
Escherichia coli. The cloning primers were based on a published cDNA sequence (Katane, M.; 
Furuchi, T.; Sekine, M.; Homma, H. Amino Acids, 2006, 32, 69.) and synthesized by Integrated 
DNA Technologies (Coralville, IA). Mouse kidney cortex was dissected and homogenized in 2 
mL of TRIzol (Invitrogen, Carlsbad, CA) and the RNA extracted from the homogenate. First 
strand cDNA was prepared from total RNA with Superscript III reverse transcriptase 
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(Invitrogen). The first strand cDNA was then PCR-amplified using platinum pfx DAN 
polymerase (Invitrogen, Carlsbad, CA) and the following primers: 5’-
GGCATATGGACACAGTGTGTATTGCGGT-3’ (forward, NdeI site underlined) and 5’-
CCGGATCCCTACAGCTTCGACAAGGAAGC -3’ (reverse, Bam HI site underlined). For 
PCR amplification, the following temperature program was used: 94 °C for 5 min (1 cycle); 94 
°C for 15 sec, 55 °C for 30 sec, and 68 °C for 80 sec (29 cycles); 68 °C for 10 min. Next, the 
target PCR fragment (~1000 bp) was isolated from an agarose gel with a QIAGEN kit, ligated to 
pCR2.1 ®-TOPO® vector (Invitrogen) and transformed into TOP10 chemically competent cells 
(Invitrogen). Ten colonies were picked from the transformation plate, grown up, and their 
plasmids purified and sequenced. A sequence-verified clone was then grown up, and the plasmid 
was isolated and digested with NdeI and Bam HI restriction enzymes (New England Biolabs, 
Ipswich, MA). The digested plasmid was then ligated to bacterial protein expression vector 
pET15b (EMD Millipore, Billerica, MA) and transformed into TOP10 cells. Following sequence 
confirmation, the clone plasmid was purified from TOP10 and transformed into BL21(DE3) cells 
(EMD Millipore). The D-AspO was then expressed by growing a 3 mL bacterial overnight 
culture at 30 °C in 250 mL Luria broth medium until OD600 reached 0.5. Next, 0.01 mM 
isopropyl β- D-1-thiogalactopyranoside was added and incubated at 30 °C for 20 h with 
continuous shaking. The bacteria culture was pelleted by centrifugation at 10,000 g for 10 min at 
4 °C. The resulting pellet was lysed with 10 mL of BugBuster Mix (EMD Millipore) 
supplemented with 2 mM dithiothreitol (DTT) and a protease inhibitor cocktail. The lysate was 
then centrifuged at 16,000 g for 20 min at 4 °C. The supernatant was mixed with 2 mL NiNTA 
resin in 10 mL NiNTA bind buffer (EMD Millipore) and incubated with rocking for 1 hr at 4 °C. 
A 24-mL Econo column (Bio-Rad Laboratories, Hercules, CA) was then gravity-packed with the 
resin. The column was washed with 40 mL NiNTA wash buffer and then protein was eluted in 7 
mL of NiNTA elution buffer. The eluted protein was concentrated to 2 ml with an Amicon Ultra 
Centrifugal filter (Thermo Fisher Scientific, Waltham, MA) and then subjected to gel filtration 
chromatography using 50 mM Tris-HCl buffer, pH 8.0, with 2 mM DTT at 1 mL/min flow rate 
with a HiPrep Sepharcryl 200 HR 16/60 column (GE Healthcare Life Sciences, Pittsburgh, PA). 
The enzyme-containing fractions were buffer exchanged by Amicon into enzyme storage buffer 
containing 50 mM NaPO4, 150 mM NaCl, pH 8.0, 20% glycerol, and 1 mM DTT, and stored at 
–20 °C until use. 
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Results and Discussion 
Comparison of CZE and LVSS-CE Separation Performance 
An LVSS-CE-LIF technique was developed for the chiral analysis of D- and L-Asp, and 
D- and L-Glu. LVSS, also referred to as large-volume sample stacking with an electroosmotic 
flow pump (LVSEP), leverages conductivity differences between the sample and background 
electrolyte (BGE), as well as the reversal of the direction of electroosmotic flow by BGE 
additives for sample stacking. The general principles of the stacking process, as well as 
information on other LVSEP methods and applications, have been well described in the review 
by Kitagawa and coworkers.60  
 In this variant of LVSS-CE-LIF, the entire capillary is filled with low conductivity 
sample. Prior to separation, analytes are compressed to a narrow band by field-enhanced 
stacking. Due to large sample loading relative to CZE-LIF, the signal for each of the stacked 
analytes increases proportionally, as opposed to being a function of electrophoretic mobility. 
This attribute of even signal gain is important in analyses where molecules of interest migrate 
near high mobility system peaks. 
 A signal enhancement of 480 ± 12-fold (x̄ ± SD) was achieved using the LVSS-CE-LIF 
chiral analysis method, as determined by comparing triplicate inter-day measurements against 
those from CZE under equivalent capillary and buffer conditions (Figure 5.1 A, B). The relative 
standard deviations of the peak areas and migration times were comparable between the LVSS 
and CZE analyses (Table 5.1). Additionally, as seen in Figure 5.1 C, the current profiles for 
both LVSS and CZE were stable and repeatable. The initial lack of current in the LVSS-CE 
current profile corresponds to the sample stacking process. Following sample preconcentration, 
the amplitude of the LVSS-CE-associated current is 97% of CZE current under identical 
separation conditions. The difference in the current amplitudes for the two methods depends on 
the extent of surface coverage with QAβCD, which dynamically coats the capillary walls during 
the sample stacking process. 
 Once the method’s repeatability was established, we confirmed its ability to resolve the 
analyte signals from system peaks. Figure 5.1 D shows a representative electropherogram from a 
single neuron from the F-cluster of Aplysia. D-Glu was not observed in most of the analyzed 
neurons. However, when present, the developed LVSS-CE method well resolves D-Glu from 
system peaks, enabling detection at trace levels (Figure 5.2 A). Our results demonstrate that the 
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LVSS-CE-LIF method is well suited for analyses of D- and L-Asp, as well as D- and L-Glu, in 
single neurons. Analyte peaks were identified by migration time, shape, and standard addition 
experiments. As shown in Figure 5.2 B, the D-Asp peak identifications were also confirmed with 
enzymatic treatment of single cell extracts by the degradative enzyme D-AspO. 
 
Effects of Inorganic Ions on Method Performance 
It is often the case that single cell samples contain inorganic ions that can interfere with 
chemical measurements. These ions include those endogenous to the biological material itself, 
but also are often sourced from the solutions used for sample preparation (e.g., cell isolation or 
culture media). These solutions are frequently comprised of millimolar quantities of inorganic 
ions, notably Na+ and Cl-. For this reason, we investigated the impact of both ions on the 
performance of the LVSS-CE-LIF method used here. 
In this experiment, 10 nM standards of D- and L-Asp, and D- and L-Glu, were analyzed by 
LVSS-CE-LIF with increasing amounts of NaCl added. The impact of NaCl levels on the current 
profile is also shown in Figure 5.3 A. Control LVSS-CE-LIF measurements of 10 nM standards, 
and CZE-LIF detections of 1 µM standards in the absence of the inorganic ions, are shown in 
Figure 5.3 B. LVSS-CE-LIF analyses were able to tolerate the presence of up to 1 mM NaCl 
without detriment to signal intensity, migration time, and current profile. More substantial 
deteriorations of signal intensity and peak shape were observable with 10 and 100 mM NaCl, 
where 100 mM NaCl induced shifts in migration time. However, even under these conditions, 
LVSS-CE-LIF produced stronger signals for the analyzed standards as compared to CZE-LIF 
analyses of the same standards at two orders of magnitude greater concentrations (Figure 5.3 B). 
The salt tolerance of this method is greater than similar LVSS approaches, typically in the low-
mid µM range.61 The resulting signal enhancement and salt tolerance are attributed to a “double 
stacking” mechanism, the combination of field-enhanced and sweeping stacking, as depicted in 
Figure 5.4. Substantial changes in the current profiles during stacking, and the analyte separation 
itself, were also observed with 10 and 100 mM NaCl (Figure 5.5).  
 Although our LVSS-CE-LIF method tolerates high levels of salt, the observed effects of 
the presence of inorganic ions on method performance prompted the inclusion of a desalting step 
to our analytical protocol. Desalting ensures that all samples are devoid of salts as opposed to 
containing unknown and variable amounts, affording more consistent migrations times and 
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signal enhancement. To this end, we developed a homemade SPE approach by packing a 200 µL 
pipette tip with polystyrene-divinylbenzene. This bed material was selected because it was 
anticipated to interact strongly with the tagged amino acids, which undergo substantial increases 
in hydrophobicity upon derivatization. The hydrophobic interactions between the 
cyanobenz[f]isoindole-amino acids and the SPE bed material enable analyte retention and 
sample desalting. In order to evaluate the developed SPE approach, a stock solution containing 
100 µM standards was diluted to achieve 10 nM levels, with reduced concentrations of other 
compounds present in the derivatization mixture. SPE-treated and control (untreated) standards 
containing 10 nM of DL-Asp and DL-Glu were analyzed in triplicate. The current traces for the 
LVSS-CE-LIF analyses of SPE-treated and diluted samples overlay well, and match the current 
profile observed from the traces measured in the absence of added inorganic ions (Figure 5.6). 
The percent recovery (x̄ ± SD), calculated for each enantiomer individually as the ratio of SPE 
and diluted standard peak areas from triplicate measurements, were 63 ± 5% for D/L-Asp, and 74 
± 6% for D/L-Glu. Thus, the overall signal enhancement from the developed approach remained 
greater than two orders of magnitude in spite of losses from the desalting step.  
 
LVSS-CE-LIF Analysis of Single Neurons 
To demonstrate the applicability of the developed approach for quantification, calibration 
plots over the range of relevant concentrations were constructed. The determined limits of 
detection were sub-pM, and R2 values were greater than 0.996 for each amino acid (Figure 5.7).  
 The contribution of analytes present in the extracellular media collected during single cell 
sample preparation was tested. We collected and analyzed 1 µL of media surrounding the neuron 
of interest, which is notably larger than what is typically transferred alongside a single cell 
during sampling. Even with this excessive volume, signals corresponding to < 5 pmol L-Asp and 
L-Glu were detected, with no signals of D-Asp and D-Glu observed (data not shown). Therefore, 
no significant influence from the extracellular media on the results of single cell analysis is 
expected. 
 Due to the irregular shape and complex morphology of the studied cells, volume 
determination by microscopy is complicated and inexact. For this reason, relative quantification 
was performed where % of D-Glu (and % D-Asp) is related to the total (L + D) Glu (and L + D 
Asp), where the variance of % D-AA is driven by the variance of the D-AA levels and not the 
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less variable and consistently high concentrations of the L-forms. Multiple neurons from the F-, 
C- and B-clusters of the Aplysia cerebral ganglion were measured individually (Figure 5.8). 
Although all three of these clusters were shown to stain positively for DAR1 protein, a large 
range of % D-Asp contents was apparent (Figure 5.8 A). The % D-Glu was much lower than % 
D-Asp in all studied cells. Interesting, unlike D-Asp, D-Glu-containing neurons were found only 
in the F- and C-clusters (Figure 5.8 B). Additionally, as can be seen in Figure 5.8, neuronal sub-
populations are observable within the datasets. 
None of the analyzed neurons demonstrated % D-Asp outside of the inner fence values 
(Figure 5.9 A). Analysis of entire F-clusters from animals of varied sizes, and thereby varied 
ages, found an anticipated age/size-dependent increase in % D-Asp (Figure 5.10). With regard to 
% D-Glu, several neurons fell outside the inner fence values (Figure 5.9 B). Additionally, the 
mode for % D-Glu datasets for each cluster equals 0. Taken together, the identified “outlier” cells 
are neurons with notably different D-AA content from the others in the dataset — in this case, the 
rare D-Glu containing neurons.   
 No correlation between the relative levels of the two D-AAs is apparent (Figure 5.11). 
This lack of correlation suggests that individual cell-specific accumulation of D-AAs can be 
involved in the observed phenomenon. Also, different enzymes may be involved in the synthesis 
of these structurally similar D-AAs. As an example, the presence of another enzyme capable of 
synthesizing D-AAs in A. californica, DAR1L, was recently shown.45 However, the cellular 
distribution of DAR1L in the Aplysia CNS, as well as the possible existence and localization of 
other enzymes that may play a role in the synthesis and degradation of D-AAs, remain unknown. 
 How confident are our assignments? The LVSS-CE-LIF approach was validated with 
measurements of D-Asp in single Aplysia neurons known to express the enzyme DAR1. 
Following peak identification by migration time and standard addition, enzymatic digestion by 
D-AspO was used to demonstrate that the measured values indeed correspond to D-Asp, and not a 
co-migrating peak. With regard to D-Glu, challenges associated with enzymatic treatment of this 
low- abundance analyte in single cell samples, combined with this enzyme’s lower efficiency in 
eliminating D-Glu, prevented us from confirming the peak identity via an enzymatic test. Thus, 
our identification of D-Glu was based on migration time, peak shape, and standard addition. 
Although peak identifications as done here for D-Glu and by others for various d-AAs34 can be 




Neurochemistry tends to be conserved across the metazoa and the presence of D-AAs 
appears to follow this trend. D-Glu has been measured at 0.5% in the rat brain,32 and 
immunocytochemical staining identified the sparse presence of D-Glu-containing cells (< 1%) in 
several regions of the rat brain.33 Our data support the idea of sparse D-Glu presence in the CNS, 
making it an intriguing and important molecule to understand. The ability to carry out single cell 
studies is important when analyzing chemical species such as D-Glu, which are heterogeneously 
distributed between cells in the targeted biological structure. The herein described variant of 
LVSS-CE-LIF enables analyses of both enantiomeric forms of aspartate and glutamate in single 
neurons, with an over two orders of magnitude sensitivity enhancement compared to the 
traditional CZE-LIF approach. The efficacy of the technique was validated by analyses of D-Asp 
and D-Glu in individual neurons from defined clusters of the cerebral ganglion of A. californica. 
Significant differences in relative contents of D-Asp and D-Glu between studied cells of differing 
origin were readily identified. Based on a rough estimation of cell size and signal intensity, the 
levels measured in these cells correspond to low μM concentrations of D-Glu and high μM to low 
mM concentrations of D- and L-Asp, as well as L-Glu. The ability to measure D-Glu in single 
neurons will aid efforts in characterizing this enigmatic D-AA, which exhibits low abundance 
and a heterogeneous distribution. 
Robust D-AA measurements make use of ancillary approaches such as analyte-specific 
enzymatic treatment as shown here, or some excellent examples from the literature.26,29,46,54 
Employing multiple analytical techniques to measure the same analytes from the same samples 
can provide greater confidence for such measurements.62 Unfortunately, these ancillary 
approaches are not always effective for single cell measurements. Our group and others have 
worked on single cell CE–MS,63-71 but these approaches need to be adapted for chiral 
measurement. Until then, the results reported here, and similar studies lacking ancillary 
confirmation for their analytes, are unconfirmed and require follow-up studies. 
 Future work will involve more in-depth single cell analyses in Aplysia and other models, 
including smaller mammalian brain cells, for the purposes of identifying neurons that utilize D-
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Figure 5.1: Comparison of CZE-LIF and LVSS-CE-LIF performance. (A) CZE-LIF 
electropherogram from the analysis of D- and L-Asp, and D- and L-Glu by CZE. (B) CZE-LIF 
electropherogram from the analysis of D- and L-Asp, and D- and L-Glu by LVSS. (C) Current 
profiles for CZE and LVSS separations (n = 3 for each method). (D) Representative 
electropherogram from the analysis of a single neuron from the F-cluster of the cerebral 




Figure 5.2: Peak identification by standard addition or enzymatic degradation. (A) 
Electropherogram from the LVSS-CE-LIF analysis of a single neuron from the F-cluster of the 
cerebral ganglion with (red) and without (black) 100 pM D-Glu spike. (B) Electropherogram 
from the LVSS-CE-LIF analysis of a single neuron from the F-cluster of the cerebral ganglion 
with (red) and without (black) enzymatic treatment by D-AspO. The peak corresponding to D-










Figure 5.3: Influences of inorganic ions on the separation and detection performance of CZE-
LIF and LVSS-CE-LIF. (A) Current profiles for LVSS-CE analyte separations with 1, 10, and 
100 uM or 1 mM NaCl, as well as without NaCl, in the injected sample plug. (B) CE-LIF 
electropherograms from the analysis of D- and L-Asp, and D- and L-Glu, with various levels of 
NaCl in the injected sample plug. a) CZE of 1 uM AAs without NaCl; b) LVSS-CE of 10 nM 
AAs without NaCl; c) LVSS-CE of 10 nM AAs in 1 uM NaCl; d) LVSS-CE of 10 nM AAs in 10 
uM NaCl; e) LVSS-CE of 10 nM AAs in 100 uM NaCl; f) LVSS-CE of 10 nM AAs in 1 mM 
NaCl; g) LVSS-CE of 10 nM AAs in 10 mM NaCl; h) LVSS-CE of 10 nM AAs in 100 mM 












Figure 5.4: Depiction of the sample stacking process in the LVSS variant. The D-AAs (red) and 
L-AAs (blue) are stacked together (shown as purple); the chiral separation initiates once regions I 
and II are excreted from the capillary inlet by electroosmotic flow. Region I: This region of the 
capillary contains a low-conductivity sample matrix (devoid of analyte as the acidic amino acids 
have migrated to region II). Region II: This is the boundary between the low-conductivity 
sample and high-conductivity BGE. Upon reaching this boundary, analytes are exposed to a 
lower separation potential as well as sweeping toward the inlet when complexed with the 



















Figure 5.5: Influences of high concentrations of inorganic ions on separation current. 
(A) Current profiles for LVSS-CE separations without, and with, 1 and 10 mM NaCl in the 














Figure 5.6: Current profile comparison to evaluate solid phase extraction efficacy. 
Overlay of current profiles from the analysis of 10 nM D- and L-AA standards following 
desalting by solid phase extraction (SPE), as well as dilution, where dilution was used to 














Figure 5.7: Calibration curves for L-Asp, D-Asp, L-Glu and D-Glu. Three technical replicates 
were performed for each analyte concentration. Data produced by the LVSS-CE-LIF method 
demonstrate linear dependence on analyte concentration over the concentration range of interest 
(10 pM–100 nM). The R2 values for all plots were greater than 0.996, and the limits of detection 










Figure 5.8: Detection of D-Asp and D-Glu in individual neurons using LVSS-CE-LIF. 
Scatterplots of (A) % D-Asp and (B) % D-Glu measured in individual neurons from the F-, C-, 
and B-clusters of the cerebral ganglion. Each point corresponds to a single cell. Number of single 
neurons analyzed per cluster, sample size (n): F-cluster, 15; C-cluster, 















Figure 5.9: Evaluation of D-Asp and D-Glu in population of analyzed neurons. Box and whisker 
plots of the relative to total amino-acid content of (A) % D-Asp and (B) % D-Glu in individual 
neurons from the F-, C-, and B-clusters of the cerebral ganglion. Asterisks indicate outlier data 
points as determined by inner fences. ◊ = Mean. Lower inner fence = Lower quartile – 
1.5*(interquartile range). Upper inner fence = Upper quartile + 1.5*(interquartile range). 
Lower/middle/upper lines indicate the 1st quartile/median/3rd quartiles, respectively. Number of 



















Figure 5.10: Relative quantification of D-amino acids in entire F-clusters from animals of 
different sizes. (A) D-Asp and (B) D-Glu in entire F-clusters from animals of different sizes, 
where the 5–20 g animals are juveniles, and the 70–80 g and 150–230 g are adult Aplysia. The 
error bars represent standard deviations for data acquired from three biological replicates. Two-





















Figure 5.11: Scatter plot of % D-Asp and % D-Glu determined for multiple individual neurons 
isolated from three different clusters of the cerebral ganglion. Each point corresponds to data 
collected from a single neuron. Sample size (n): F-cluster neurons, 15; C-cluster neurons, 17; B-
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Capillary Electrophoresis Advances and Applications for the 




This chapter includes three projects regarding capillary electrophoresis, D-amino acids and 
bioanalysis. Each of these projects did not advance to the point where they could be published. 
With that said, each project has yielded exciting results and are great prospects for eventual 
publication and contributions to the fields of analytical chemistry, D-amino acids and biology. 
The projects described herein include: 
 
• Online preconcentration approaches for the measurement of the D-amino acids by 
capillary electrophoresis  
• Nanovial concentrators to facilitate sample preparation of volume-limited samples 
• D-amino acid analysis in rat and human pancreatic islets by chiral liquid chromatography, 
capillary electrophoresis and mass spectrometry 
 
Each project is discussed with a succinct introduction, experimental, results and 
conclusions. This is done to facilitate readability and the ability to place the work in the 
appropriate context. All projects were supported from the National Science Foundation through 
grant CHE 16-067915. The project regarding the study of the D-amino acids in rat and human 
pancreas and pancreatic islets was additionally supported by the American Diabetes Association 
through the ADA visionary award to J. V. Sweedler. Assistance for the design and fabrication of 
the nanovial concentrators by Michael Harland and characterization of the devices by 
undergraduate assistant Joshua Jones are acknowledged for the project regarding the 
development of nanovial concentrators. For the project focused on measuring the D-amino acids 
in rat and human pancreas and islets of Langerhans, support for rat dissections and sample 
preparation by Dr. Stanislav Rubakhin, islet culture and isolation by Dr. Troy Comi and David 
Mast, chemical analysis by Dr. Ning Yang, undergraduate assistants Joshua Jones and Jack 
Schnieders as well as graduate assistant Cindy Lee are acknowledged. Furthermore, the support 
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of Dr. Ali Naji from the University of Pennsylvania as well as Dr. Mark Atkinson from the 
University of Florida is greatly appreciated, their assistance with preparing and providing human 
pancreas and islet samples was critically important. 
 
Section 6.1: Online Preconcentration Approaches for the Measurement of the 
D-Amino Acids by Capillary Electrophoresis 
 
Introduction 
Capillary electrophoresis (CE) is a liquid phase separation technique which applies high 
voltage across narrow-bore capillaries to achieve separations on the basis of charge and size. 
Capillary electrophoresis has been employed for the separation of a large variety of compound 
classes, including inorganic ions,1,2 amino acids3-9 and strands of ribonucleic acids.10,11 Beyond 
chemical separations, CE approaches have been developed for the separation of bacteria12 
nanoparticles.13 Although the original anticipation of displacing liquid chromatography as the 
most widely employed liquid phase separation technique was not met, capillary electrophoresis 
continues to see growing use, particularly for rapid and volume-limited analyses. The popularity 
of capillary electrophoresis for these areas emanates from low mass detection limits, utilization 
of plug flow over parabolic flow and high separation efficiencies.14-17 
 An additional strength of capillary electrophoresis is the ability to develop and 
incorporate online preconcentration approaches in order to achieve even lower detection limits 
than conventional capillary electrophoresis methods. There are a variety of mechanisms which 
can be leveraged, and an astonishing number of online stacking variants have been developed, 
characterized and/or employed. The fundamental principles and demonstrations of online 
preconcentration in capillary electrophoresis have been well reviewed.18-20  
 Of the many preconcentration paradigms, large-volume sample stacking is a set of 
approaches which relies on a field-amplification effect to stack the analytes. What makes large-
volume sample stacking unique from field-amplified sample stacking is the volume of sample 
introduced into the capillary, where LVSS injects larger volumes, typically 10-20-fold greater.19 
This difference leads to signal enhancement factors of at least two orders of magnitude for LVSS 
variants. An additional strength of LVSS approaches is the fact that the extent of signal 
enhancement is related to injected volumes as opposed to electrophoretic mobility, as is seen 
with electrokinetic stacking mechanisms. This difference results in equal signal enhancement 
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factors across analytes, simplifying method development and data analysis as well as preventing 
high mobility system peak ions from obfuscating the measurement of near-migrating analytes. 
To enable the measurement of low abundance species in volume-limited samples, several online 
preconcentration methods were developed. While Chapter 5 reports a CE-LIF approach for the 
chiral analysis of aspartate and glutamate, reported here are: a large-volume sample stacking 
method compatible with capillary electrophoresis-mass spectrometry (CE-MS), a polarity-
switching large-volume sample stacking CE-LIF method for the separation and measurement of 
D- and L-serine and a large volume sample stacking CE-LIF method for the analysis of 
kynurenine. Additionally, the feasibility of multi-fill large-volume sample stacking (MF-LVSS) 
for greater signal enhancements was explored. The preliminary results from each of these 
method development efforts are presented. 
 
Experimental  
Materials and Chemicals  
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless stated otherwise. 
Aqueous solutions were prepared with ultrapure deionized (DI) water from an ELGA Purelab 
Ultra water system (USFilter, Lowell, MA). All aqueous solutions were stored at 14 °C 
following initial preparation. Naphthalene-2,3-dicarboxaldehyde (NDA) was purchased from 
Invitrogen (Carlsbad, CA). Quaternary ammonium β-cyclodextrin (QAβCD) and gamma-
cyclodextin (γCD) were purchased from CTD Holdings (Alachua, FL).  
 
Capillary Zone Electrophoresis (CZE)-LIF 
Separations were performed with a PA 800 plus Pharmaceutical Analysis System with 
LIF detection (AB SCIEX, Framingham, MA). This system was coupled to an external diode 
laser (56ICS426, Melles Griot, Carlsbad, CA) with a fiber optic cable (OZ Optics, Ottawa, ON, 
Canada).  The laser emission wavelength was 440 ± 8 nm, and the laser was operated at 3 mW. 
The LIF detection module utilizes a 490 ± 15 nm band-pass filter (Omega Optical, Brattleboro, 
VT) to prevent light not corresponding to the fluorescence emission band from reaching the 





Online Preconcentration CE-LIF 
In order to avoid impurities, buffer solutions were prepared in deionized (DI) water. The 
background electrolyte solution for the capillary electrophoresis-mass spectrometry amenable 
large-volume sample stacking method was an aqueous solution of 15 mM ammonium acetate 
and 5 mM sodium chloride to which 140 uL of 30% ammonium hydroxide was added. The 
polarity switching stacking method for the analysis of D- and L-serine buffer was prepared 
diluting a 100 mM sodium tetraborate decahydrate (pH 9.5) buffer to 67 mM with DI water, and 
thereafter dissolving the sodium dodecylsulfate and γ-CD additives into this diluted solution. For 
the kynurenine large-volume sample stacking and multi-fill large-volume sample stacking 
methods, 250 mL of 280 mM MES buffer (pH 6.00) was prepared by dissolving 14.7 g of MES 
hydrate (4.7% H2O) in 200 mL of DI water, adjusting pH with 1.0 M NaOH, followed by 
dilution to volume with DI water. A 10% (w/v) QAβCD solution was prepared by dissolving 
0.490 g of QAβCD in 4.9 mL of DI water. Additionally, 200 mM KBr was prepared by 
dissolving 2.39 g of KBr into 100 mL of DI water. The final concentrations for the kynurenine 
large-volume sample stacking separation buffer were 50 mM MES (pH 6) and 100 ppm QAβCD. 
The separation buffer for the multi-fill large-volume sample stacking was prepared by mixing the 
prepared solutions to final concentrations of 60 mM MES (pH 6), 10 mM KBr and 110 ppm 
QAβCD. Prior to use, the separation buffers were degassed by sonication. 
Bare fused-silica capillaries (Polymicro Technologies, Phoenix, AZ) were used for all 
separations. Prior to initial use, capillaries were treated with 0.1 M NaOH for 30 min. The 
separation buffer was replenished prior to each separation. Whole capillary volume sample 
injection was performed hydrodynamically for all methods. For the CE-MS compatible LVSS 
method, a 40.2/50.2 cm effective length/total length capillary with 40/360 μm ID/OD was used. 
The separation voltage for this method was 20 kV. In order to achieve electroosmotic flow 
reversal, the capillary was rinsed 0.6 M hydrochloric acid in methanol for 1.5 min prior to 
loading the low conductivity sample. Sample solutions were dissolved in 0.5% acetic acid in 
methanol. The polarity switching online preconcentration and chiral separation of serine was 
achieved with a 30.2 cm capillary with an effective length of 20.2 cm. The inner and outer 
diameters were 50 μm and 360 μm respectively, and the voltage and temperature were 12 kV and 
18℃ respectively. The kynurenine large-volume sample stacking method utilized a 40.2 cm long 
capillary, with an effective length of 30.2 cm, with 50/360 μm ID/OD. The separation voltage 
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was -20 kV and the temperature was 18℃.  A 60.2 cm capillary with an effective length of 50.2 
cm and 76.2/360 ID/OD was used for the multi-fill analyses. The multi-fill method involved the 
following steps in order: Rinse capillary for 1 min with 0.5 M NaOH, rinse capillary for 1.5 min 
with DI water, fill capillary with low conductivity standard/sample for 0.2 min at 16 psi, online 
concentration with -21 kV voltage application for 2.25 min, fill capillary with low conductivity 
standard/sample for 0.15 min for 18 psi, online concentration with -21 kV voltage application for 
2.25 min, fill capillary with low conductivity standard/sample for 0.15 min for 18 psi, and finally 
online concentration and separation with -21 kV voltage application for 40 min. The capillary 
temperature was 20℃ for all steps of the method. OriginPro 2015 software (Origin Lab 
Corporation, Northampton, MA) was used for data analysis.   
 
Sample Derivatization  
Derivatization procedures for the amino acid standards for LIF detection were 
accomplished by mixing the aqueous standard with NDA (20 mM in acetonitrile) and potassium 
cyanide (KCN) (saturated in acetonitrile, 20 °C) in a 1:1:2 ratio. The reaction mixture was 
pipetted repeatedly to achieve mixing. The reaction was allowed to proceed for one hour in the 
dark at 20–24 °C. SAFETY NOTE: our NDA reaction protocol involves the use of unbuffered 
KCN and should be carried out in a fume hood while following safety procedures to minimize 
exposure risk. Alternative reaction protocols can also be considered. With regard to the 
acetylation of the kynurenine standards, the standards, prepared in ethyl acetate, were mixed with 
acetic anhydride in a 15:2 volume ratio and allowed to react for two hours. Following the 
reaction, the solvent was dried off and the reaction products were reconstituted in water prior to 
analysis. 
 
Results and Discussion 
 In the following sections the analyte stacking mechanisms and initial method 
characterization findings are shared for the proof-of-concept efforts regarding the development 
of capillary electrophoresis preconcentration methods for CE-MS and CE-LIF. The following 
stacking variants all take advantage of field-amplified stacking to achieve signal enhancements 
exceeding two orders of magnitude. The early method development findings for a multi-fill 
large-volume sample stacking approach are also shared. 
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LVSS Method Development for CE-MS Applications 
 A large-volume sample stacking capillary electrophoresis method which is amenable for 
coupling with electrospray ionization-mass spectrometric detection was developed. Unlike many 
other LVSS methods which reverse the direction of electroosmotic flow following analyte 
concentration through the use of charged surfactants (e.g. cetrimonium bromide), the developed 
method manipulates the surface charge through acid-base chemistry and solvent composition. 
Specifically, the capillary is initially rinsed with the acidic condition solution, where the solvent 
is methanol, in order to result in a positively charged inner surface (Table 6.1). The sample 
solution is also an acidic methanol solution, however, with much less conductivity than the 
aqueous and basic ammonium acetate background electrolyte. As shown in Table 6.1, the 
introduction of the background electrolyte during the sample stacking process results in a 
reversal of the direction of the electroosmotic flow.  
 Similar to other variants of LVSS-CE, this method leverages the difference in 
conductivity of the sample plug and background electrolyte, which typically differ by at least 
two orders of magnitude. With these criteria met the method can compress analytes within the 
large-volume sample plug to a narrow band. As shown in Figure 6.1, the method current equals 
zero during the stacking phase and then stabilizes at the separation current during the separation 
phase. For the developed method the running current for the method was 85 µA and found to be 
stable under the separation conditions.  
 
LVSS Polarity Switching Method Development for Chiral Analysis of Serine by CE-LIF 
 A variant of polarity switching large-volume sample stacking capillary electrophoresis 
with laser-induced fluorescence (PS-LVSS-CE-LIF) method was developed for the separation 
and analysis of D-serine, L-serine, L-glutamate and glycine. The PS-LVSS-CE-LIF approach 
granted 120-fold signal enhancement and reduced total separation time of the method from 25 
minutes to under 22 minutes. As seen in Figure 6.2, all analyte peaks are resolved with both 
CZE and PS-LVSS-CE-LIF, however, there was a detriment to the resolution of D- and L-serine 






LVSS Method Development for Analysis of Kynurenine by CE-LIF 
 In order develop a capillary electrophoresis method with a lower limit of detection than a 
traditional capillary zone electrophoresis method for the analysis of the biogenic amine 
kynurenine, a variant of large-volume sample stacking was developed. As shown in Figure 6.3, a 
14-fold signal enhancement was achieved with the developed LVSS-CE-LIF method. The level 
of signal enhancement was an order of magnitude lower than what is typically seen with the 
employed separation and capillary parameters. The reduced analyte stacking is attributed to the 
pKa profile of the molecule, where the strongest base pKa of 8.96 requires high sample plug pH 
to achieve effective sample stacking. This presented a challenge because the sample plug 
requires low conductivity for LVSS. This issue was addressed through the tagging of the amine 
groups of kynurenine via a reaction with acetic anhydride. The resulting acetylated kynurenine 
exhibits a pKa profile which is amenable for the anionic form to exist in the neutral sample plug. 
The acetylating of kynurenine resulted in an additional 9-fold signal gain for the developed 
LVSS-CE-LIF method, as shown in Figure 6.4, for a total of over 120-fold signal enhancement 
compared to CZE. 
 
Development of MF-LVSS-CE-LIF Method 
 As an exploratory effort, a variant of large-volume sample stacking capillary 
electrophoresis with laser-induced fluorescence was developed. The developed method iterated 
sample filling and sample stacking processes prior to separation and measurement of D- and L-
aspartate. The ability to incorporate multiple sample filling and stacking processes into a method 
enables the usage of larger reconstitution volumes for simpler sample handling, usage of 
automated commercial instruments and injection of greater amounts of sample, among other 
sample handling benefits. The current profile for a LVSS-CE-LIF method for the measurement 
of D- and L-aspartate is shown in Figure 6.5 A. The current profiles for the first sample injection, 
second sample injection and third sample injection immediately followed by the separation phase 
of the method are shown in Figure 6.5 B, C and D respectively. It is evident that the current 
profiles for the various phases of the MF-LVSS-CE-LIF method fit together piecewise to mirror 
the profile of the LVSS-CE-LIF method, thus demonstrating that method is working under the 
multi-fill paradigm. As displayed in Figure 6.6, although the analytes were indeed stacked in the 
developed by MF-LVSS-CE-LIF, there was a noteworthy detriment to peak shape. Importantly, 
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the D- and L-forms of aspartate were baseline resolved and the analytes did not exhibit peak 
splitting, further demonstrating the feasibility of multi-fill large-volume sample stacking. 
 
Conclusions and Future Directions 
Each of the described method development efforts demonstrated the capabilities, or at 
least feasibility, of novel sample preconcentration variants of large-volume sample stacking 
capillary electrophoresis. The proof-of-concept experiment all yielded promising results and 
warrant parameter optimization. The methods developed for the LVSS analysis of kynurenine 
and serine both demonstrated over two orders of magnitude signal enhancement. Although the 
signal enhancement factor for the CE-MS amenable variant was not ascertained, the theoretical 
enhancement is calculated to be just over 1000-fold using a 1 meter, 40 µm ID capillary. 
Impressively, the multi-fill large-volume sample stacking method demonstrated the ability to 
repeated load and preconcentrate sample prior to analysis, theoretically granting an infinite 
volume of sample to be loaded and preconcentrated. More realistically, once optimized this 
would enable the ability to inject nearly all (~90%) of a sample’s volume using a commercial 
instrument — trivializing single cell measurements by removing the requirement of a high level 
of skilled user interfacing and also granting opportunities for higher-throughput via auto-
sampling. 
 




The past decades have seen impressive examples of single cell measurements, resulting 
from the development, refinement and application of sensitive analytical methodologies. These 
single cell, and subcellular, measurements have been achieved with a variety of techniques.5,6,21-
29 With regard to metabolomic and peptidomic measurements involving a chemical separation 
for improved analyte detection and identification – capillary electrophoresis has been leveraged 
heavily as the separation technique of choice.5,6,26,27,30-32 The reliance on capillary electrophoresis 
for volume-limited samples is tied to the exquisitely low mass detection limits of capillary 
electrophoresis methods.  
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Unfortunately, analysis of volume-limited samples, such as individual cells, involves 
overcoming a variety of analytical challenges beyond those routinely encountered in 
bioanalytical measurements. As an example, to minimize sample dilution prior to analysis, 
custom vials have been developed and employed.6,27 For example, reconstitution of a 5 um 
diameter neuron isolated from Bos taurus (assumed as a perfect sphere) in 250 nL corresponds to 
nearly 500,000-fold dilution. This level of dilution results in low analyte concentrations, and 
therefore the avoidance of even further dilution is highly desired. Beyond detection limit 
challenges, working with single cell, subcellular and other volume-limited samples are also 
burdened with challenges associated with sample acquisition, handling, transfer, and scalability. 
To this point, a substantial degree of single cell measurements still requires a high level of user 
involvement. In order to facilitate sample preparation and processing in a scalable way – 
nanovial concentrators were designed, fabricated and characterized. Use in single cell, 
subcellular, storage, collaboration is anticipated. The preliminary results of this effort are shared. 
 
Experimental  
Materials and Chemicals  
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless stated otherwise. 
Aqueous solutions were prepared with ultrapure deionized (DI) water from an ELGA Purelab 
Ultra water system (USFilter, Lowell, MA). All aqueous solutions were stored at 14 °C 
following initial preparation. Naphthalene-2,3-dicarboxaldehyde (NDA) was purchased from 
Invitrogen (Carlsbad, CA). Gamma-cyclodextin (γCD) was purchased from CTD Holdings 
(Alachua, FL). 
 
Nanovial Concentrator Fabrication 
 Nanovial concentrator vials were designed in order to nest a 0.079-inch diameter 
nanovial between two interlocking components. The interlocking components were machined 
out of polychlorotrifluoroethylene, a chlorofluoropolymer which is a non-wetting material with 
good chemical resistance, high tensile strength and is nonflammable. The bottom vial component 
included a 0.010-inch cavity into which the bottom of a loaded nanovial could rest. When fully 
assembled, the nanovial concentrator is 2.24-inches in length. The headspace above the nanovial, 
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when the device is assembled, has a depth of 0.77-inches to enable the loading of approximately 
500 µL of solution for concentration into a nanovial. 
 
Sample Loading Evaluation by Fluorescence Microscopy 
The ability to deposit fluorescein into the cavity of a nanovial with the developed 
nanovial concentrator devices were evaluated by whole-slide fluorescence microscopy using an 
Axio Imager M2 (Carl Zeiss, Jena, Germany). Florescence imaging of fluorescein deposition 
was done with a 10× objective and excitation wavelength of 513 nm via an X-CITE 120 mercury 
lamp (Lumen Dynamics, Mississauga, Canada). 
 
Sample Derivatization  
Derivatization procedures for the serine standards for LIF detection were accomplished 
by mixing the aqueous standard with NDA (20 mM in acetonitrile) and potassium cyanide 
(KCN) (saturated in acetonitrile, 20 °C) in a 1:1:2 ratio. The reaction mixture was pipetted 
repeatedly to achieve mixing. The reaction was allowed to proceed for one hour in the dark at 
20–24 °C. SAFETY NOTE: our NDA reaction protocol involves the use of unbuffered KCN and 
should be carried out in a fume hood while following safety procedures to minimize exposure 
risk. Alternative reaction protocols can also be considered.  
 
Percent Recovery Evaluation by Capillary Zone Electrophoresis (CZE)-LIF 
Separations were performed with a PA 800 plus Pharmaceutical Analysis System with 
LIF detection (AB SCIEX, Framingham, MA). This system was coupled to an external diode 
laser (56ICS426, Melles Griot, Carlsbad, CA) with a fiber optic cable (OZ Optics, Ottawa, ON, 
Canada).  The laser was operated at 3 mW with an emission wavelength of 440 ± 8 nm. In order 
to ensure that light only corresponding to the fluorescence emission band reached the 
photomultiplier tube detector, a 490 ± 15 nm band-pass filter (Omega Optical, Brattleboro, VT) 
was incorporated into the detection setup. The separation of D- and L-serine by capillary 
electrophoresis was achieved with a background electrolyte comprised of final 60 mM MES (pH 
6), 10 mM KBr, and 220 ppm QAβCD.  The separation buffer was prepared by mixing 
appropriate amounts of 280 mM MES buffer, 200 mM KBr, and 10% (w/v) QAβCD solutions 
and DI water.  The 280 mM MES buffer (pH 6) was prepared by dissolving 14.7 g of MES 
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hydrate (4.7% H2O) in 200 mL of DI water, and the pH was adjusted with 0.1 M NaOH.  The 
solution was then diluted to 250 mL with DI water.  The 200 mM KBr solution was prepared by 
dissolving 2.39 g of KBr in 100 mL of DI water.  To prepare the 10% (w/v) QAβCD solution, 
0.0790 g of QAβCD was dissolved in 0.790 mL of DI water.  Prior to use, the separation buffers 
were degassed. Bare fused-silica capillaries (Polymicro Technologies, Phoenix, AZ, USA) were 
used for these separations.  Specifically, a 40.2 cm capillary with an effective length of 30.2 cm 
to the detector was used.  The inner and outer diameters of the capillaries were 50 μm and 360 
μm respectively. Prior to use, capillaries were treated with 0.1 M NaOH for 30 minutes.  
Additionally, capillaries were rinsed with 0.5 M NaOH, DI water, and separation buffer for 2 
minutes each prior to analysis.  The voltage and temperature were 18 kV and 18 ℃ respectively. 
Data analysis was completed using OriginPro 2015 software (Origin Lab Corporation, 
Northampton, MA, USA). 
 
Results and Discussion 
Nanovial Concentrator Design and Experimental Workflow 
 A simple device comprised of two interlocking components, which nest a nanovial in the 
center when assembled, was designed and fabricated out of polychlorotrifluoroethylene. This 
device, deemed a nanovial concentrator, enables the loading of up to 500 µL of solution into the 
device cavity (Figure 6.7). The concentration of the solution results in the deposition of any 
solute into the cavity of the nested nanovial. The polychlorotrifluoroethylene material was 
selected for its low adsorption properties, to minimize analyte losses during sample 
concentration. Fabrication drawings of the nanovial concentrator top and bottom are found in 
Figure 6.8 and Figure 6.9 respectively. This device facilitates the usage of larger handling 
volumes during sample acquisition and preparation while still allowing low reconstitution 
volumes for sample analysis. Figure 6.10 shares an example workflow for the usage of the 
nanovial concentrators for the handling and analysis of minute sample amounts following patch 
clamp electrophysiology. Current workflows for the handling of such minute sample amounts 
require manual manipulation of small sample volumes, inevitably leading to signal loss and poor 
reproducibility. As seen in Figure 6.11, the nanovial concentrators do an effective job depositing 
material into the cavity of the nanovial, whereas manual deposition results in sample loss onto 
the rim of the nanovial. 
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Conclusions and Future Directions 
 The developed nanovials have been partially characterized, demonstrating their usability 
for the preparation of low-volume samples (e.g. 250 nL) in spite of the advantage of working 
with larger volumes, up to 500 µL, during sample handling. Beyond minimizing the impact of 
pipet performance and transfer bias at low volumes, the developed nanovial concentrators 
facilitate scalability for sample preparation. The conventional approach requires the loading of 
nanovials manually, necessitating a high degree of user skill and interfacing, whereas nanovial 
concentrators can prepare samples in batches with a centrifuge concentrator. Once fully 
characterized, application for single cell and subcellular metabolomics is anticipated. 
 
Section 6.3: D-Amino Acid Analysis in Rat and Human Pancreatic Islets by 




 The pancreas is abdominal organ which is essential to processes pertaining to organismal 
nourishment. Specifically, the exocrine pancreas, referring to exocrine glands contained within 
the organ, support digestion of macronutrients (fats, proteins and carbohydrates) through the 
secretion of digestive enzymes.33 The endocrine pancreas, referring to pancreatic islets, is 
responsible for the maintenance of blood glucose homeostasis through the monitoring of blood 
glucose levels as well as the production and secretion of hormones to coordinate the uptake, 
usage, storage and release of glucose throughout the body.34 When blood glucose levels increase, 
this is detected by beta cells and in response insulin hormone is released into the bloodstream. 
Analogously, when circulating levels of glucose fall, this is detected by alpha cells within the 
pancreatic islets and in response glucagon hormone is secreted into the bloodstream.  
 Considering the involvement in important nutrition processes, a properly functioning 
pancreas is critical for organismal health. It follows that the disrupted functioning of the diseased 
pancreas, as is seen with type 1 diabetes (T1D) and type 2 diabetes (T2D), has significant health 
implications. These impacts include metabolic complications,35 fatigue36 and greater 
susceptibility to death from other diseases.37 Consequently, the signaling pathways and 
transmitters involved in healthy and diseased pancreas function remain important areas of 
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research. With a detailed understanding of the molecular basis to pancreas function, the medical 
community is afforded additional opportunities for intervention and better patient outcomes. 
 The functional roles of a suite of transmitters, such as insulin, glucagon, GABA,38 and 
acetylcholine,39 has been investigated within the healthy and diseased pancreas. Unlike the 
aforementioned signaling molecules, less is known about the signaling capacity and functional 
significance of a class of rare molecules demonstrated to be present, the D-amino acids (D-AAs). 
Specifically, the presence of D-alanine (D-Ala),7,40-42 D-aspartate (D-Asp)43 and D-serine (D-
Ser)44,45 in the pancreas of various animals has been demonstrated. Beyond presence, evidence 
supporting potential involvement of D-AAs in islet signaling has been uncovered. Regarding D-
Ala, glucose stimulation experiments have demonstrated that this D-AA is co-released alongside 
insulin from pancreatic islets.7 Additionally, experiments in gnotobiotic mice has demonstrated 
that the overwhelming majority of pancreatic D-Ala is derived from gut microbes.46 Regarding D-
Ser, expression of serine racemase in mouse and human islet beta cells has been demonstrated.45 
Moreover, it was observed through serine racemase knockout experiments that there is a 
relationship between D-Ser and glucose tolerance. Here we report our findings from the 
investigation of the D-AAs in rat and human pancreas.  
 
Experimental  
Materials and Chemicals  
Unless stated otherwise, chemicals were purchased from Sigma-Aldrich (St. Louis, MO). 
Aqueous solutions were prepared with ultrapure deionized (DI) water from an ELGA Purelab 
Ultra water system (USFilter, Lowell, MA). All aqueous solutions were stored at 14 °C 
following initial preparation. Naphthalene-2,3-dicarboxaldehyde (NDA) was purchased from 
Invitrogen (Carlsbad, CA). Quaternary ammonium β-cyclodextrin (QAβCD) and gamma-
cyclodextin (γCD) were purchased from CTD Holdings (Alachua, FL). LC-MS grade methanol 
was purchased from Alfa Aesar (Haverhill, MA) and LC-MS grade water was purchased from 
Thermo Fisher Scientific (Waltham, MA).  
 
Rat Pancreas and Pancreatic Islet Sample Preparation 
Adult male (1-2 months old) Sprague-Dawley rats (Envigo, Madison, WI) were 
euthanized using carbon dioxide asphyxiation — animals were euthanized in accordance with the 
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appropriate institutional animal care protocols (the Illinois Institutional Animal Care and Use 
Committee), and in full compliance with federal guidelines for the humane care and treatment of 
animals. Pancreatic islets were isolated manually from an enzymatically digested and 
mechanically treated pancreas, in the same manner as previous reports.47 The islet isolation is 
concisely described here; 2 mL of 1.4 mg/mL collagenase P (Roche Diagnostics, Indianapolis, 
IN ) in modified Gey’s balanced salt solution (mGBSS) supplemented with 5 mM glucose and 
1% (w/v) bovine serum albumin (BSA) is injected into the pancreas through the bile duct. The 
mGBSS contained 5 mM D-glucose, 1.5 mM CaCl2, 4.9 mM KCl, 0.2 mM KH2PO4, 11 mM 
MgCl2, 0.3 mM MgSO4, 138 mM NaCl, 27.7 mM NaHCO3, 0.8 mM NaH2PO4, and 25 mM 
HEPES dissolved in Milli-Q water (Millipore, Billerica, MA), with the pH adjusted to 7.2. The 
pancreas was then dissected and placed into 8 mL of the collagenase P solution. To facilitate the 
dissociation of the pancreas tissue, the solutions were incubated in a recirculating water bath for 
20−30 min at 37 °C with agitation. Excess collagenase P was washed from the tissue with 
mGBSS containing glucose and BSA. Next, the treated tissues were centrifuged for 3 min at 
300g, and the resulting tissue pellet was dispersed into mGBSS, and islets were manually 
isolated via micropipette. For the isolation of islets and acinar tissue, the pancreas tissue was 
incubated in a recirculating water bath for 20-30 minutes at 37℃ to digest the exocrine tissue 
while predominately leaving the islets intact.  The resulting suspension was washed with mGBSS 
twice and then centrifuged at 300g for 3 minutes.  The supernatant was removed via pipette and 
the pellet was resuspended in 10 mL of mGBSS.  The manually isolated islets and acinar tissue 
were transferred into tubes containing 500 μL of cold mGBSS, to which 50 μL of methanol was 
added. The samples were sonicated for 10 minutes at 20℃ and centrifuged at 20,817 x g for 15 
minutes, next the supernatant was taken via pipet and dried with a Savant SpeedVac concentrator 
(Thermo, Milford, MA, USA).  The dried samples were stored at -20℃ until analysis. 
Islets were cultured overnight prior to homogenization and extraction; pancreas tissue 
extractions were carried out directly after dissection. For the pulse-chase measurements, 10 mM 
L-alanine-1-13C-containing media was used for overnight culture. For glucose stimulation 
experiments, the pancreatic islets were incubated at 37℃ in D-glucose-containing media for one 
hour. Pancreas tissue and isolated islet homogenate samples were prepared by sonication for 10 
minutes at 20℃ in pure methanol. Next, the homogenate was centrifuged at 20,817 x g for 20 
minutes to pellet cellular debris. The resulting supernatant was transferred to a clean tube via 
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pipet and dried with a Savant SpeedVac concentrator (Thermo, Milford, MA). All dried samples 
were stored at -20 ℃ until reconstituted in DI water directly prior to analysis. 
 
Human Pancreas and Pancreatic Islet Sample Preparation  
Unfixed islets isolated from human pancreas were provided from the lab of Dr. Ali Naji 
from the University of Pennsylvania in accordance with approved Institutional Review Board 
protocols. High-purity (>80%) islets were isolated according to a previously published 
protocol.48 Fixed pancreas sections were prepared and provided by Dr. Mark Atkinson’s lab at 
the University of Florida. Extractions were performed with fresh human islets by homogenizing 
in pure methanol with a pestle and thereafter sonicating for ten minutes. Analytes were extracted 
from 14 µm thick sections of fixed human pancreas by sonicating in methanol for ten minutes. 
Next, the supernatant from either sample type was pulled following centrifugation at 20,817 x g 
for 20 minutes to pellet solid debris. The collected extract solutions were dried with a Savant 
SpeedVac concentrator (Thermo, Milford, MA). The samples were reconstituted in DI water 
prior to analysis. 
 
Chiral Liquid Chromatography with Mass Spectrometry (LC-MS) 
An EVOQ Elite Triple Quadrupole Mass Spectrometer coupled with an Advance UHPLC 
module (Bruker Daltonics) was the instrument platform used for this work. The analytical 
separations were achieved with an Astec CHIROBIOTIC T2 chiral HPLC column which utilizes 
a teicoplanin-based stationary phase — 5 μm particle size, 200 Å pore size, 25 cm (length) × 4.6 
mm ID (Astec, Whippany, NJ, USA). A simple isocratic multisolvent mobile phase was used 7.7 
mM ammonium hydroxide and 27 mM formic acid in 72/28 methanol/water, flow rate, 1000 
μL/min. The mass spectrometer source parameters were: spray voltage (HESI): ± 4500 V; cone 
temperature: 250 °C; cone gas flow: 10; heated probe temperature: 450 °C; probe gas flow: 15; 
nebulizer gas flow: 60; exhaust gas: off. The resulting chromatograms were analyzed by Data 
Review 8.2 (Bruker Daltonics).  
The analyte retention times and fragmentation parameters were established from the 
simultaneous analysis of a mixture of DL-Ala, DL-Asp and DL-Ser standards. The parameter 
values for alanine measurement were: detection window time: 10 minutes; L-form elution time: 
4.5 minutes; D-form elution time: 7.1 minutes; scan time: 500 milliseconds; polarity: positive. 
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The multiple reaction monitoring channels for alanine were: 1) 90.20 -> 44.40; collision energy: 
8.00; Q1 resolution: unit; Q3 resolution: unit; scan time: 50%; quantifier ion; 2) 90.20 -> 62.30; 
collision energy: 5.00; Q1 resolution: unit; Q3 resolution: unit; scan time: 50%; qualifier ion. For 
the stable heavy isotope measurements of alanine, the mass transitions 91.20 -> 45.40 and 91.20 
-> 63.30 were used with the other parameters unchanged. The parameter values for aspartate 
measurement were: detection window time: 10 minutes; L-form elution time: 4.3 minutes; D-
form elution time: 5.6 minutes; scan time: 500 milliseconds; polarity: positive. The multiple 
reaction monitoring channels for aspartate were: 1) 134.20 -> 74.20; collision energy: 11.00; Q1 
resolution: unit; Q3 resolution: unit; scan time: 33%; quantifier ion; 2) 134.20 -> 88.20; collision 
energy: 8.00; Q1 resolution: unit; Q3 resolution: unit; scan time: 33%; qualifier ion; qualifier 
ratio: 45.9 3) 134.20 -> 116.10; collision energy: 5.00; Q1 resolution: unit; Q3 resolution: unit; 
scan time: 33%; qualifier ion; qualifier ratio: 70.0. The parameter values for serine measurement 
were: detection window time: 10 minutes; L-form elution time: 4.0 minutes; D-form elution time: 
4.8 minutes; scan time: 500 milliseconds; polarity: positive. The multiple reaction monitoring 
channels for serine were: 1) 106.10 -> 60.20; collision energy: 15.00; Q1 resolution: unit; Q3 
resolution: unit; scan time: 33%; quantifier ion; 2) 106.10 -> 88.10; collision energy: 15.00; Q1 
resolution: unit; Q3 resolution: unit; scan time: 33%; qualifier ion; qualifier ratio: 0.0; 3) 106.10 
-> 70.30; collision energy: 15.00; Q1 resolution: unit; Q3 resolution: unit; scan time: 33%; 
qualifier ion; qualifier ratio: 0.0. 
 
Sample Derivatization  
Derivatization procedures for the standards and samples for laser-induced fluorescence 
detection were achieved by mixing the aqueous standard mixture or sample with 20 mM NDA 
(in acetonitrile (ACN)) and a saturated potassium cyanide in acetonitrile (20 °C) in a 1:1:2 ratio. 
Mixing was achieved by repeatedly pipetting the reaction mixture. The derivatization reaction 
was allowed to proceed in the dark for one hour at 20–24 °C. SAFETY NOTE: our NDA 
reaction protocol involves the use of unbuffered KCN and should be carried out in a fume hood 
while following safety procedures to minimize risk of cyanide exposure. Alternative protocols 




In order to confirm the presence of D-Asp, we treated some samples with D-AspO, 
similarly, for confirmation of D-Ala and D-Ser presence, D-AAO treatment was employed. For D-
Asp confirmation, several amino acid standards and tissue/islet homogenates were treated 
according to our published protocol.9 Briefly, standards and homogenates were mixed with D-
AspO (4.6 mg/mL), FAD (5 mM), and catalase (68 µg/mL) in a 1:0.6:1:1 volume ratio. For D-
AAO treatment, the standards and homogenates were mixed with D-AAO (1.8 mg/mL) FAD (5 
mM), and catalase (68 µg/mL) in a 1:2:1:1 volume ratio. Next, the reaction mixture was 
incubated in a water bath at 37 °C for 6 h. Each enzyme-treated sample was dried and 
reconstituted in 1 µL of water prior to derivatization and analysis by capillary electrophoresis 
coupled with laser-induced fluorescence in accordance with a previously published protocol.  
 
Chiral Capillary Electrophoresis with Laser-Induced Fluorescence (CE-LIF) 
Capillary electrophoresis separations were performed with a PA 800 plus Pharmaceutical 
Analysis System (AB SCIEX, Framingham, MA). This capillary electrophoresis system was 
coupled to an external diode laser (56ICS426, Melles Griot, Carlsbad, CA) with a fiber optic 
cable (OZ Optics, Ottawa, ON, Canada) to enable laser-induced fluorescence (LIF) detection.  
The laser emission wavelength for the LIF platform was 440 ± 8 nm, where the laser was 
operated at 3 mW. A 490 ± 15 nm band-pass filter (Omega Optical, Brattleboro, VT) was 
incorporated into the LIF detection module to prevent light not corresponding to the fluorescence 
emission band from reaching the photomultiplier tube detector.  
Chiral separation of D- and L-aspartate was achieved with a background electrolyte with 
final concentrations of 60 mM MES (pH 6), 10 mM KBr and 110 ppm QAβCD.  The capillary 
zone electrophoresis separation of D- and L-Ser was achieved with a buffer composed of 60 mM 
MES (pH 6), 10 mM KBr and 220 ppm QAβCD.  The above described capillary zone 
electrophoresis coupled with laser-induced fluorescence separation buffers were prepared by 
mixing the appropriate amounts of aqueous solutions of 280 mM MES buffer, 200 mM KBr and 
10% (w/v) QAβCD and DI water.  The 280 mM MES buffer (pH 6) was prepared by dissolving 
14.7 g of MES hydrate (4.7% H2O) in 200 mL of DI water, followed by pH adjustment with 0.1 
M NaOH.  Once the solution reached pH 6, the buffer was diluted to 250 mL with DI water.  The 
200 mM KBr solution was prepared by dissolving 2.4 g of KBr in 100 mL of DI water.  To 
prepare the 10% (w/v) QAβCD solution, 79 mg of QAβCD was dissolved in 790 µL of DI water.  
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For the chiral separation of D- and L-Ala by micellar electrokinetic chromatography (MEKC) a 
separation buffer with final concentrations of 67 mM sodium tetraborate decahydrate (pH 9.5), 
90 mM SDS and 10 mM γ-CD was used. The buffer was prepared by diluting a 100 mM sodium 
tetraborate decahydrate (pH 9.5) buffer with DI water. The 100 mM sodium tetraborate 
decahydrate buffer was prepared by dissolving 7.6 g of sodium tetraborate decahydrate in 150 
mL of DI water. The pH of this solution was adjusted to 9.5 with 0.1 M NaOH prior to diluting 
to a final volume of 200 mL.  In order to incorporate the sodium dodecylsulfate and γ-CD 
additives, each compound was dissolved directly into the borate buffer. All separation buffers 
were degassed prior to use. 
Bare fused-silica capillaries (Polymicro Technologies, Phoenix, AZ, USA) were used for 
all capillary electrophoresis and micellar electrokinetic chromatography separations.  For the 
chiral separations for aspartate and serine, a 40.2 cm capillary with an effective length of 30.2 
cm was employed.  For the chiral separation of alanine, a 30.2 cm capillary with an effective 
length of 20.2 cm was used.  The inner and outer diameters of all capillaries were 50 μm and 360 
μm respectively. Prior to their initial use, all capillaries were treated with 0.1 M NaOH for 30 
minutes. Additionally, prior to each analysis, capillaries were sequentially rinsed with 0.5 M 
NaOH, DI water and separation buffer for 2 minutes each. Regarding the chiral separation of 
aspartate, the voltage and temperature were -26 kV and 18 ℃ respectively.  For the separation of 
D- and L-serine, the voltage and temperature were 18 kV and 18 ℃ respectively.  The voltage 
was 12 kV and temperature was 15 ℃ for the micellar electrokinetic chromatography separation 
of D- and L-alanine.  Data analysis for all capillary electrophoresis separations was completed 
using OriginPro 2015 software (Origin Lab Corporation, Northampton, MA, USA). 
 
Results and Discussion 
D-Amino Acid Measurements in Rat Pancreas and Islets by Capillary Electrophoresis-Laser-
Induced Fluorescence 
 Rat pancreas tissue homogenates were analyzed by capillary zone electrophoresis 
approaches for the measurement of the D- and L-forms of alanine, aspartate and serine. 
Representative electropherograms depicting the resolved D-AA peaks from the many system 
peaks are shown in Figure 6.12. In order to verify the identity of the D-Ala and D-Ser peaks in 
the measurements, pancreas homogenate samples were also analyzed following treatment with 
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D-AAO. The D-AAO enzyme treatment resulted in the degradation of the analyte peaks 
identified by migration time and analyte spiking, confirming the peak identity (Figure 6.13). The 
D-Asp peak was confirmed through migration time, peak profiles and analyte spiking. 
 Following confirmation of the efficacy of the CE-LIF methods for the measurements of 
the D-AAs of interest in rat pancreas samples, multiple pancreata homogenate samples were 
analyzed for all three D-AAs. Additionally, endocrine pancreas, which consists of isolated 
pancreatic islets, and exocrine pancreas homogenates were analyzed for D-Ala. The relative D-
AA levels are shared in Table 6.2 as the mean ± SD, where the relative concentrations are 
calculated as the amount of the D-form of a given AA divided by the total amount of the same 
AA in the sample. Interestingly, the exocrine pancreas was shown to contain a greater relative 
amount of D-Ala than the endocrine pancreas, although the relative amounts of D-Ala in the 
exocrine pancreas exhibited more biological variability than the D-Ala levels in the pancreatic 
islets. This finding is unexpected as the immunohistochemical staining by Morikawa and 
coworkers40 did not show positive staining of the exocrine pancreas. Both D-Asp and D-Ser were 
measured in the pancreas tissue homogenate, the higher than anticipated relative amounts 
suggest these D-AAs may also be present in the exocrine tissue. 
 
Measurements of Alanine in Rat Pancreatic Islet Homogenate by Liquid Chromatography-
Mass Spectrometry 
 The homogenate of pancreatic islets isolated from rat pancreas were analyzed following 
stimulation with low (3 mM), moderate (6 mM) and high (12 mM) D-glucose in mGBSS media, 
the levels of D- and L-alanine were determined by liquid chromatography mass spectrometry, 
utilizing a triple quadrupole mass spectrometer in multiple reaction monitoring mode. As 
depicted in Figure 6.14, stimulation with each of the tested glucose concentrations resulted in an 
increase the % D-Ala relative to the no stimulation control. This determination of an increase in 
% D-Ala in vitro suggests that pancreatic islets are able to locally produce D-alanine, clashing 
with the prevailing thought that this D-amino acid is gut-derived. 
 Following up on the evidence for local D-Ala production in rat pancreatic islets, pulse-
chase experiments with stable heavy L-Ala were performed. The analysis of homogenate from 
pancreatic islets incubated overnight in media containing L-Ala labeled with stable heavy 
carbon-13 found unlabeled D-Ala to be present, but not labeled D-Ala (Figure 6.15). This finding 
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suggests that D-Ala, if produced within islets, is not produced from the action of an alanine 
racemase. Put differently, the L-Ala which we demonstrated to be uptaken by the pancreatic 
islets (Figure 6.15) was not converted to D-Ala. Consequently, other synthetic precursors should 
be analyzed in order to further understand local production of D-Ala in rat islets. 
 
D-Amino Acid Measurements in Human Pancreas and Islets by Liquid Chromatography-Mass 
Spectrometry and Capillary Electrophoresis-Laser-Induced Fluorescence 
 Homogenate from freshly isolated healthy human pancreatic islets was analyzed by a 
polarity switching large-volume sample stacking capillary electrophoresis with laser-induced 
fluorescence method for the analysis of D- and L-serine. The PS-LVSS-CE-LIF measurement 
found 1% D-Ser relative to total serine in the homogenate (N = 1 biological replicate), Figure 
6.16 A. Extract from a fixed section of healthy human pancreas was analyzed by chiral liquid 
chromatography-mass spectrometry for D- and L-alanine, D- and L-aspartate as well as D- and L-
serine. The L-forms of alanine, aspartate and serine as well as the D-form of serine were detected, 
neither D-Ala nor D-Asp were measured in the analyzed sample. The detection of D-Ser in the 
fixed tissue extract (N = 1 biological replicate) is depicted in Figure 6.16 B. The direct 
measurement of D-serine supports the positive immunostaining for serine racemase and D-Ser by 
Lockridge and coworkers.45 
 
Conclusions and Future Directions 
The direct measurement of D-serine in the healthy human pancreas and endocrine 
pancreas tissues in this exploratory effort support the immunohistochemical findings of 
Lockridge and coworkers. Additionally, due to the fact that D-serine localizes to beta cells within 
pancreatic islets and that beta cell populations are known to decrease in both T1D and T2D, 
analysis of the relationships between D-serine levels in the healthy diseased pancreas warrants 
further investigation. Additionally, although neither D-alanine nor D-aspartate were detected in 
this effort, analysis of a greater number of samples with these or more sensitive LC-MS and CE-
LIF approaches would help further our understanding of whether or not these D-AAs are also 









Figure 6.1: Current profile for large-volume sample stacking method amenable for capillary 













Figure 6.2: Stacked electropherograms from the analysis of a selection of amino acid standards 
by capillary zone electrophoresis (Black) and the developed polarity switching large-volume 
sample stacking capillary electrophoresis (Red) methods. The amino acids have concentrations 
of 1 µM and 10 nM for the CZE and PS-LVSS-CE analyses respectively. Peaks in the 












Figure 6.3: Stacked electropherograms from the analysis of kynurenine standards by capillary 
zone electrophoresis (Black) and the developed large-volume sample stacking capillary 
electrophoresis (Red) methods. The concentration of kynurenine was 250 µM for both the CZE 














Figure 6.4: Stacked electropherograms from the analysis of kynurenine (Black) and acetylated-
kynurenine (Red) by the developed large-volume sample stacking capillary electrophoresis 













Figure 6.5: Comparison of current profiles for large-volume sample stacking and multi-fill-
large-volume stacking. (A) Current profile for large-volume sample stacking. (B) Current profile 
from the first sample loading and stacking segment of the MF-LVSS-CE-LIF method. (C) 
Current profile from the second sample loading and stacking segment of the MF-LVSS-CE-LIF 
method. (D) Current profile from the final sample loading and stacking segment and separation 

















Figure 6.6: Electropherogram from the analysis of 100 nM D- and L-aspartate standards by the 















Figure 6.7: Drawing of the design of the developed nanovial sample concentrator tubes. The 
lower body and upper body screw together, sealing the nanovial in between. Up to 500 µL of 





















Figure 6.8: Fabrication drawings of the top component of the nanovial concentrator tube. The 
device component was machined out of polychlorotrifluoroethylene. The reported lengths are 










Figure 6.9: Fabrication drawings of the bottom component of the nanovial concentrator tube. 
The device component was machined out of polychlorotrifluoroethylene. The reported lengths 







Figure 6.10: Schematic of workflow for sample deposition into nanovials for subsequent 




















Figure 6.11: Fluorescence microscopy images of nanovials comparing hand-spotting to the 
deposition device. From top to bottom: empty control, hand-spotted 1 uL of 1 nM fluorescein, 






Figure 6.12: Representative electropherograms from the analysis of rat pancreas by CE-LIF. (A) 
Chiral analysis of aspartate; Peaks in the electropherograms: (1) L-Aspartate, (2) D-Aspartate. (B) 









Figure 6.13: Peak identification by enzymatic degradation. (A) Electropherogram from the CE-
LIF analysis of rat pancreas homogenate with (Red) and without (Black) enzymatic treatment by 
D-AAO. The peak corresponding to D-Ala is degraded with enzymatic treatment. (B) 
Electropherogram from the CE-LIF analysis of rat pancreas homogenate with (Red) and without 









Figure 6.14: Box and whisker plots of the relative levels of D-alanine in rat pancreatic islet 
homogenates as determined by LC-MS. Each measurement (◊) corresponds to homogenate from 
~100 islets following stimulation with 3 mM (Red), 6 mM (Blue) or 12 mM (Pink) D-glucose or 
no stimulation (Black). The upper and lower fences correspond to the range of each population. 







Figure 6.15: Representative chromatograms from the chiral analysis of alanine by liquid 
chromatography mass spectrometry in multiple reaction monitoring mode of rat pancreatic islet 
homogenate following incubation with balanced salt media containing 6 mM D-glucose and 10 
mM L-alanine. The stacked chromatograms correspond to unlabeled alanine (Red) and 
isotopically labeled alanine (Blue). The monitored transitions for the Red and Blue 
chromatograms were 90.20 -> 44.40 and 91.20 -> 45.40 respectively. Peaks: Left = L-alanine; 








Figure 6.16: Analysis of human-derived pancreas and pancreatic islet samples. (A) 
Electropherogram resulting from the analysis of freshly isolated human pancreatic islets for D- 
and L-serine with PS-LVSS-CE-LIF. (B) Extracted ion chromatogram, for transition 106.10 Da -
> 60.20 Da, resulting from the analysis of fixed human pancreas tissue for D- and L-serine with 
LC-MS. The * symbol designates D-Ser. N = 1 biological replicate (for both the unfixed isolated 










Table 6.1: Summary of the capillary inner surface charge and direction of electroosmotic flow 
when exposed to conditioning solution, sample solution and background electrolyte under 



























Table 6.2: Determined relative concentrations of the D-forms of alanine, aspartate and serine 
relative to total alanine, aspartate and serine respectively. Endocrine pancreas refers to isolated 
pancreatic islets and exocrine pancreas refers to pancreas tissues devoid of islets. Values reported 
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Conclusions and Outlook  
 
 
Decades of research following the initial uncovering of the D-amino acids in nature have 
led to the development of an extensive archive on the ubiquitous presence of the molecules 
themselves as well as various proteins which enable their production, transport, degradation and 
signal transduction, as described in Chapter 2. These many discoveries stand atop the shoulders 
analytical chemistry – where advances with liquid chromatography, capillary electrophoresis, gas 
chromatography, biosensors, histology and sampling have enabled the uncovering and 
characterization of the D-amino acids and related proteins across the Metazoa, as discussed in 
Chapter 3. In parallel with analytical advances, functional roles for the D-amino acids were 
increasingly uncovered and characterized in the central nervous and endocrine systems in 
vertebrate and invertebrate animals. Chapter 4 provides a synthesized overview of the findings 
from investigations of D-aspartate as a transmitter in nonmammalian animals. Similarly, the 
efforts of labs around the world have led to the establishment of D-serine as a transmitter with 
known signaling pathways and functional roles. With this said, progress on the discovery and 
characterization of other D-amino acids in animals has been plagued with a battery of 
experimental challenges. Specifically, these other D-amino acids (e.g. D-alanine, D-glutamate and 
D-proline) remain difficult to study due to heterogenous distributions, low abundances and a lack 
of knowledge on associated genes and proteins. Accordingly, there continues to be a demand for 
methodological improvements which address these and other bioanalytical challenges to enable 
continued measurement and characterization of the D-amino acids in increasingly challenging 
experimental conditions.  
 The work described in the second half of this thesis focuses on my efforts to address the 
aforementioned challenges in the field. Chapter 5 describes a large-volume sample stacking 
chiral capillary electrophoresis method I developed and characterized. The method was found to 
enhance sensitivity by nearly 500-fold for DL-aspartate and DL-glutamate while performing 
similarly to capillary zone electrophoresis with regard to migration time and repeatability. 
Considering the challenges associated with high salt content in samples for large-volume sample 
stacking and analytical methods more generally, a solid phase extraction method was developed 
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and characterized. The developed desalting approach was effective at removing salts present at 
high millimolar levels, enabling application of the developed method to salt containing samples. 
The application of the developed approach to individual neurons isolated from the B-, C- and F-
clusters of the Aplysia californica cerebral ganglion provided a means to validate the method’s 
performance through the well-characterized D-aspartate. Additionally, this work successfully 
measured the enigmatic D-glutamate and revealed differences in distribution and abundance 
relative to D-aspartate. Chapter 6 describes three projects regarding novel methods and 
applications for the measurement of the D-amino acids in a variety of biological systems. The 
first of these project focuses on the development of several online preconcentration methods for 
capillary electrophoresis measurements. Specifically, a large-volume sample stacking method 
which is amenable for metabolomics experiments via capillary electrophoresis couple with mass 
spectrometry and a large-volume sample stacking method and derivatization protocol for the 
measurement of kynurenine. Another aspect for this project was the investigation on the 
feasibility of multi-fill large-volume sample stacking for even greater signal enhancements. The 
second project described in this chapter is focused on the development of nanovial concentrators 
which enable the preparation of volume-limited samples in a manner which is scalable, simple 
and which minimizes signal loss due to sample handling. Finally, the third project described in 
Chapter 6 describes the work done on the analysis of the D-amino acids in rat and human 
pancreas and pancreatic islets by liquid chromatography coupled with mass spectrometry and 
capillary electrophoresis coupled with laser-induced fluorescence. Although the three projects 
described in this chapter have not reached publishable quality, they have yielded interesting 
preliminary results and are great prospects for future investigations regarding the D-amino acids, 
kynurenine, metabolomics and volume-limited samples. 
 Beyond finalizing the methods described in Chapter 6 and continuing to explore the D-
amino acids in the pancreas and pancreatic islets, there are many important questions in the field 
of D-amino acids which the Sweedler is in prime position to address. Specifically, application of 
the suite of methods developed in the Sweedler lab over the years will facilitate the 
characterization of the less understood D-alanine and D-glutamate in the central nervous, enteric, 
exocrine and endocrine systems. Little is known about the enzymatic production of these 
molecules in animals in spite of a substantial understanding of clearance mechanisms and 
degradative proteins. The Sweedler lab is well-positioned to uncover of additional racemases, 
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transaminases or other means of producing the D-amino acids in animals. Considering the gaps 
which continue to exist in the catalog of D-amino acid-related proteins experimentally suggested 
to exist but yet discovered, such a development would be a major step forward for the field. 
Regarding the D-amino acids more generally, the characterization of microbially-derived D-
amino acids with regard to endogenous levels, physiology and pathology are rapidly growing 
areas of interest. Currently, investigations in the intestine are at the tissue level, blending D-
amino acid signals across many cells types and/or bacterial species. With the continuously 
growing capabilities of the Sweedler lab in targeted sampling and volume-limited sample 
analysis, the group is well-positioned to execute challenging measurements in this system and 
help glean information on functional significance. Returning to the islet work shared in Chapter 
6, none of the D-amino acids demonstrated to be present and/or released are considered 
transmitters in this system. Further chemical and physiological characterization of D-alanine, D-
aspartate and D-serine may well establish these molecules as paracrine or autocrine transmitters 
in the islets. Finally, although great progress on analytical approaches which enable the 
measurement of the D-amino acids in a variety of non-ideal sample conditions have been 
developed, the continued improvement of these methodologies with improved limits of 
detection, lower sample requirements and greater throughput is highly desired. As new 
challenges to measurement are uncovered, it is anticipated that the Sweedler lab will continue to 
lead the field of analytical chemistry and develop approaches to enable currently out of reach 
measurements to be made. 
 
